Neurological Effects
of Mercury & Toxic Metal Exposure
B. Windham (Ed.) 2023
I. Introduction
There has been a huge increase in the incidence of
degenerative neurological conditions in virtually all Western countries over
the last 2 decades (574,580,598).
Neurodegenerative Conditions
are
increasing due to increased inflammation from
vaccinations
and
excitotoxicity
(12b). Much of the damage occurs during brain development which occurs in
pregnancy or the first 2 years after birth. Increased glutamate outside neuron
cells is a factor in such, triggering excitotoxicity and death of neuron cells.
Inflammation from toxic exposures such as toxic metals and pesticides is also a
common cause of such damage.
Inflammation caused by vaccines or
other sources can trigger microglial priming which causes microglia and
macrophages to secrete high levels of inflammatory cytokines which damage
neurons(12b). Riboflavin or Thiamin deficiency can be a factor in neurodegeneration
& is beneficial(12b): (R5P& B1);
L-Carnitine (12a) was protective
of damage by low oxygen and impaired blood flow, as well as reducing Autism
& ADHD. L-Carnitine (12a) was protective of damage by low oxygen and
impaired blood flow, as well as reducing Autism & ADHD.
Toxic
metals such as mercury, lead, cadmium, etc. have been documented to be
neurotoxic, and according to U.S. Government agencies to cause
adverse health effects and learning disabilities to millions in the U.S. each
year, especially
children
and the elderly(160,105,27d).The
health effects of toxic metals are
synergistic
with other toxic exposures such
as
pesticides
, herbicides,& other
endocrine
disrupting substances
like organochlorine compounds
,
POP
s,
PAHs
, PCBs, etc. There
are also synergistic effects with the various types of parasites, bacteria,
viruses to which people have common exposures and commonly become infected when
the immune system is weakened by toxic exposures (485,469b,470,581). Studies have
found considerable genetic variability in
susceptibility
to toxic metals
as well. While there is considerable commonality to the health
effects commonly caused by these toxic metals, and effects are cumulative
and
synergistic
in many cases,
this paper will concentrate on the health effects of elemental
mercury from amalgam fillings. Toxic exposures are common, since the Food
System is highly contaminated with
Toxic
Metals
,
Pesticides
,
Forever Chemicals (PFAS, etc
.),
Microplastics
, etc.
Mercury amalgam
dental fillings have been found to be the
largest source of both inorganic and methyl
mercury
in
most who have several amalgam fillings. Those with several amalgam
fillings have been found by hundreds of thousands of medical lab tests to have
mercury exposure levels approximately 10 times the average level of those
without amalgam, and saliva and excretion levels decline 90% after amalgam
replacement.
Clinical
experience has identified some of the factors that cause mercury to accumulate
in various areas of the body (581). These include past physical
trauma to an area, inflammation, food allergies, Geopathic Stress, scars and
dental trauma, structural abnormalities, biochemical deficiencies such as zinc,
environmental toxicity, and unresolved psychological problems
.
Dozens of
health conditions have been traced back to the influence of gut microbes,
including obesity, depression, chronic fatigue syndrome, Parkinson’s, allergies
and cancer.
Recent research shows gut microbes control antitumor immune
responses in your liver, and that antibiotics can alter the composition of
immune cells in your liver, triggering tumor growth.
Certain gut bacteria promote inflammation, which is an
underlying factor in virtually all cancers and chronic diseases, whereas others
quell it.
Targeting the gut microbiome could be a real game-changer in the
fight against disease.
II.
Neurological Effects of Mercury and Toxic Metals
Studies
have found that mercury is neurotoxic (kills or damages brain cells and nerve
cells) (19,27,34,36,43,69,70,147,148,175,207,211,258,273,
291,295,327,329,301,303,305,395/39,262, 274,303); generates high levels
of reactive oxygen species(ROS) and
oxidative stress, depletes glutathione and thiols causing increased
neurotoxicity from interactions of ROS, glutamate, and dopamine
(13,56,98,102, 145,169,170, 184,213,219,250,257,259,286,288,290,291,302,324,
326, 329,416,424, 442, 496,564,565); kills or inhibits
production of brain tubulin cells (66,67,161,166,
207,258,300); inhibits production of neurotransmitters
by inhibiting: calcium-dependent neurotransmitter
release(372,432),
dihydroteridine
reductase (27,122,257,333), nitric
oxide synthase(259), blocking neurotransmitter amino acids
(412), causes abnormal migration of neurons in the cerebral
cortex(149), and effecting phenylalanine,
serotonin, tyrosine and tryptophan transport to neurons (34,122,126,257,
285,288,333,372,374,412/333) Part of the toxic effects of mercury, lead,
cadmium, etc. are through their replacing essential minerals such as zinc at
their sites in enzymes, disabling the necessary enzymatic
processes.
While
there have been large increases of most neurological and immune conditions
among adults over the last 2 decades(574), the incidence of neurotoxic
or immune reactive conditions in infants such as
autism, schizophrenia
,
ADD, dyslexia, learning disabilities
, etc. have been increasing
especially rapidly in recent years (2,409,441,476). A
report by the National Research Council found that 50% of all pregnancies in
the U.S. were resulting in prenatal or postnatal mortality, significant birth
defects, developmental neurological or immune conditions, or otherwise
chronically unhealthy
babies(
441). Exposure
to toxic chemicals or environmental factors appear to be a factor in as much as
28 percent of the 4 million children born each
year(
441,160),
with 1 in 6 having one of the neurological conditions previously listed. EPA
estimates that over 3
million
of these are
related to
lead or mercury
toxicity (2,125,276,409), with approximately 25%
of U.S. infants receiving dangerous levels of mercury
exposure(276). A study found that prenatal Hg exposure is correlated
with lower scores in neurodevelopmental screening, but more so in the
linguistic pathway(32c). A study at the U.S. CDC found "statistically
significant associations" between certain neurologic developmental disorders
such as attention deficit disorder r(ADD) and autism with exposure to mercury
from thimerosal‑ containing vaccines before the age of 6 months(475,476), and a
follow on study using federal vaccine data bases confirmed that autism,
speaking disorders, and heart arrest have increased exponentially with
increasing exposures to mercury thimerosal-containing
vaccines(476b). Thimerosal has also been found to cause
hormonal effects (555,413). Prenatal exposure to mercury has also been
found to predispose animals and infants to seizures and
epilepsy
(5,52,475). There
is evidence supporting a link between the aluminum hydroxide used in vaccines
causing brain inflammation and symptoms associated with Parkinson's,
amyotrophic lateral sclerosis (Lou Gehrig's disease), and Alzheimer's (585).
Brain inflammation has also been found to be a factor in autism.
A large epidemiological study,
NHANES III
, by
the National Institute for Health has found a significant correlation between
several chronic health conditions and having more than average number of dental
amalgam surfaces. The conditions in which the number of dental amalgam
surfaces were most highly correlated with disease incidence were MS,
epilepsy, migraines, mental disorders, diseases of the nervous system,
disorders of the thyroid gland, cancer, and infectious diseases
(543). Other conditions where incidence was significantly correlated
with having more than the average number of amalgam surfaces
are:
diseases of the male and female genital tracts, Disorders of the peripheral
nervous system, Diseases of the respiratory system, and Diseases of the
genitourinary system (543).
There
has been a huge increase in the incidence of degenerative neurological
conditions in virtually all Western countries over the last 2 decades
(574,581). The increase in Alzheimer’s has been over 300% while the increase in
Parkinson’s and other motor neuron disease has been over
50%. The primary cause appears to be increased exposures to
toxic pollutants (574).
Oxidative
stress and reactive oxygen species (ROS) have been implicated as major factors
in neurological disorders including stroke, PD, MS,
Alzheimer’s, ALS, MND, FM, CFS, etc.
(13,35c,56,84,98,145,169,207b,258,424,442-444,453,462,496,581). Mercury induced
lipid peroxidation has been found to be a major factor in mercury’s
neurotoxicity, along with leading to decreased levels of glutathione
peroxidation and superoxide
dismustase
(
SOD)(13,254,489,494-496,577). Metalloprotein
(MT) is involved in metals transport and detoxification (442,464). Mercury
inhibits sulfur ligands in MT and in the case of intestinal cell membranes
inactivates MT that normally bind cuprous ions (477), thus allowing
buildup of copper to toxic levels in many and malfunction of the Zn/Cu SOD
function. Exposure to mercury results in changes in
metalloprotein compounds that have genetic effects, having both structural
and catalytic effects on gene expression
(114,241,296,297,442,464,477,495). Some of the processes affected by such
MT control of genes include cellular respiration, metabolism, enzymatic
processes, metal-specific homeostasis, and adrenal stress response systems.
Significant physiological changes occur when metal ion concentrations exceed
threshold levels. Such MT formation also appears to have a relation
to autoimmune reactions in significant numbers of people
(114,60,313,342,369,442,464).
Of a
population
of over 3000 tested by the immune lymphocyte reactivity test(MELISA,60,275),
22% tested positive for inorganic mercury and 8% for methyl mercury .
Programmed cell death(apoptosis)
is documented to be a major factor in degenerative neurological conditions like
ALS, Alzheimer’s, MS, Parkinson’s, etc. Some of the factors
documented to be involved in apoptosis of neurons and immune cells include
inducement of the inflammatory cytokine Tumor Necrosis Factor-alpha(
TNFa
) (126), reactive oxygen species and oxidative
stress(13,43b,56a,296b), reduced glutathione levels(56,126a,111a), inhibition
of protein kinase C(43), nitric oxide and
peroxynitrite
toxicity(43a), excitotoxicity (490,496,521,524), excess free cysteine
levels(56d,111a),excess glutamate toxicity(13b, 416e), excess dopamine toxicity
(56d,13a), beta-amyloid generation(462), increased calcium influx toxicity
(416e,296b,333,432,462c,507)and DNA fragmentation (296,297) and
mitochondrial membrane dysfunction (56d,416e,51a).
Mitochondrial DNA mutations or damage are
important contributors to aging and degenerative diseases
(297b,298), and mercury is common cause of mitochondrial DNA damage and
degeneration (296,297a,56d,416e,51a). Pyrroloquinoline Quinone (PPQ), an
essential micronutrient many are deficient in, has been found to improve
such damage (299).
TNFa
(tumor necrosis factor-alpha) is a
cytokine that controls a wide range of immune cell response in mammals,
including cell death(apoptosis). This process is involved in
inflammatory and degenerative neurological conditions like ALS, MS, Parkinson’s,
rheumatoid arthritis, etc. Cell signaling mechanisms like
sphingolipids are part of the control mechanism for the
TNFa
apoptosis mechanism(126a). Glutathione is an amino acid that
is
a normal
cellular mechanism
for controlling apoptosis. When glutathione is depleted in the
brain, reactive oxidative species increased, and CNS and cell
signaling mechanisms are disrupted by toxic exposures such as mercury, neuronal
cell apoptosis results and neurological damage. Mercury has been shown to
induce
TNFa
and deplete glutathione, causing
inflammatory effects and cellular apoptosis in neuronal and
immune cells(126b,126c).
Another neurological effect of mercury
that occurs at very low levels is inhibition of nerve growth factors, for which
deficiencies result in nerve degeneration. Mercury vapor is lipid
soluble and has an affinity for red blood cells and CNS cells(21a). Only
a few micrograms of mercury severely disturb cellular function
and inhibits nerve growth
(175,147,226,255,305,149). Prenatal or neonatal exposures have been
found to have lifelong effects on nerve function and susceptibility to toxic
effects. Prenatal mercury vapor exposure that results in levels of
only 4 parts per billion in newborn rat brains was found to cause decreases in
nerve growth factor and other effects (305
).This
is a level that is common in the population with several amalgam fillings or
other exposures (500). Insulin-like-growth factor I (IGF-I) are
positively correlated with growth hormone levels and have been found to be the
best easily measured marker for levels of growth hormone, but males have been
found more responsive to this factor than women (497). IGF-I controls the
survival of spinal motor neurons affected in ALS during development
as well as later in
life(
497,498). IGF-I
and insulin levels have been found to be reduced in ALS patients with
evidence this is a factor in ALS (497,498). Several clinical
trials have found IGF-I treatment is effective at reducing the damage and
slowing the progression of ALS and Alzheimer’s with no medically
important adverse effects (498). It has also been found that in
chronically ill patients the levels of pituitary and thyroid hormones that
control many bodily processes are low, and that supplementing both
thyrotropin-releasing hormone and growth control hormone is more effective
at increasing
all of
these hormone levels in the
patient.
Mercury
can cause
depression
and mood disorders through
increased neurological problems related to lowered levels of neurotransmitters
dopamine,
serotonin,
noreprenephrine
,
and acetylcholinesterase
(35,38,104,107,125,140,141,175,251,254,275,288,290,296,297,305,365,367,
372,381,432,451,465,412,581,582). In such cases mercury has been found to
accumulate in and affect the function of the brain limbic
system(
581). The reduced neurotransmitter levels in those
with amalgam appear to be a factor encouraging smoking since nicotine increases
these neurotransmitter levels and a much higher percentage of those with
amalgam smoke than in those without
amalgam(
141).
Some
of the effect on depression is related to mercury’s effect of reducing the
level of posterior pituitary hormone(oxytocin). Low
levels of pituitary function are associated with depression and suicidal
thoughts and appear to be a major factor in suicide of teenagers and other
vulnerable groups. The pituitary glands of a group of dentists
had 800 times more mercury than controls (99). This may explain
why dentists have much higher levels of emotional problems, depression,
suicide,etc
(Section VIII.). Amalgam
fillings, nickel and gold crowns are major factors in reducing
pituitary function (35,50,369, etc.). Supplementary oxytocin
extract has been found to alleviate many of these mood problems (35),
along with replacement of metals in the mouth (Section VI.). The
normalization of pituitary function also often normalizes menstrual cycle
problems, endometriosis, and increases fertility (35,9).
Animal
studies of developmental effects of mercury on the brain have found significant
effects at extremely low exposure levels, levels commonly seen in those with
amalgam fillings or in dental staff working with amalgam. One study
(305) found prenatal mercury vapor exposure decreased NGF concentration in
newborn rat’s forebrain at 4 parts per billion(ppb) tissue
concentration. Another study (175) found general toxicity
effects at 1 micromole(
uM
) levels in immature cell
cultures, increased immunoreactivity for glial fibrillary protein at 1
nanamole
(0.2 ppb) concentration, and microglial response
at even lower levels. Other animal studies on rodents and monkeys
have found brain cellular migration disturbances, behavioral changes, along
with reduced learning and adaption capacity after low levels of mercury vapor
exposure (149,175,210,264,287,305). The exposure levels in these
studies are seen in the fetus and newborn babies of
mother’s
with amalgam fillings or who had work involving amalgam during pregnancy
(61). Mercury vapor has been found to primarily affect the central
nervous system, while methyl mercury primarily affects the peripheral
nervous system(175c).
Long
term occupational exposure to low levels of mercury can induce slight cognitive
deficits, lability, fatigue, decreased stress tolerance, etc. Higher levels
have been found to cause more serious neurological problems (
119,128,160,285,457,etc.
). Other
studies(285bg,395) found that workers exposed at high levels at least 20 years
previous(
urine peak levels above 600 ug/L demonstrated
significantly decreased strength, decreased coordination, increased tremor,
paresthesia, decreased sensation, polyneuropathy, etc. Significant
correlations between increasing urine mercury concentrations and prolonged
motor and sensory distal latencies were established(285g). Elemental
mercury can affect both motor and sensory peripheral nerve conduction and the degree
of involvement is related to time‑integrated urine mercury
concentrations. Thirty percent of dentists with more than average
exposure were found to have neuropathies and visuographic dysfunction compared
to none in the control group(395d). Other studies have also
found a connection between mercury with peripheral neuropathy and paresthesia
(190,449,502,71bdef,395,581,582). Chronic mercury exposure has been
found to be a significant factor in many neurological conditions
including
Alzheimer’s, Dementia
,
Parkinson’s
,
MS
,
etc. Neurological problems are among the most common and serious problems
caused by mercury and include memory loss, moodiness,
depression
,
anger and sudden bursts of
anger/rage/violence
(290,465,480-483,487,534),
self-effacement, suicidal thoughts, lack of strength/force to resolve doubts or
resist obsessions or compulsions, etc. Many studies of patients with major
neurological diseases have found evidence amalgam fillings may play a major
role in development of conditions such as depression
(94,107,109,212,222,271,294,212,229, 233,285e,317,320,322,372,374,453,581,582),
schizophrenia (34,35,295,465,560), bipolar disorder (294), memory problems
(212,222,581,582), and other more serious neurological diseases such as
MS
,
ALS
,
Parkinson’s
,
and
Alzheimer’s
. A large U.S. CDC study found that
those with more amalgam fillings have significantly more chronic health
problems, especially neurological problems and cancer (543).
Some
factors that have been documented in depression are low serotonin levels,
abnormal glucose tolerance(hypoglycemia), and low folate
levels(
480-83), which mercury has also been found to be a
cause of. Occupational exposure to mercury has been documented to
cause depression and
anxiety(
534). One
mechanism by which mercury has been found to be a factor in aggressiveness and
violence is its documented inhibition of the brain neurotransmitter
acetylcholinesterase (175,251c,305,451,465,254). Low serotonin
levels and/or hypoglycemia have also been found in the majority of those with
impulsive and violent
behavior(
481,482).
Numerous
studies have found long term chronic low doses of mercury cause neurological,
memory, behavior, sleep, hearing
loss(
566), and mood
problems (3,34,60,69,70,71,74,107-109,119,140,141,160,199,212,222, 246,255,257,
282,290,453,581,582). Neurological effects have been documented at very low
levels of exposure (urine Hg< 4 ug/L), levels commonly received by those
with amalgam
fillings(
290). One of the studies at
a German
University(
199) assessed 20,000
people. There is also evidence that fetal or infant exposure causes
delayed neurotoxicity evidenced in serious effect at middle
age(
255,306). Organic tin compounds formed from amalgam are
even more neurotoxic than mercury
(222,262). Studies of
groups of patients with amalgam fillings found significantly more neurological,
memory, mood, and behavioral problems than the control
groups. (3,34,107,108,109,140,141,160,199,212,222,290,453,581,582).
Other studies(285c)
found that mercury at levels below the current occupational safety limit causes
adverse effects on memory at very low exposure levels. More studies
found that long term exposure causes increased micro nuclei in lymphocytes and
significantly increased
IgE
levels at exposures below
current safety
levels(
128), as well as maternal
exposure being linked to mental retardation(110). Very high levels of mercury
are found in brain memory areas such as the cerebral cortex and hippocampus of
patients with diseases with memory related symptoms (158,34,
207,etc.
} Mercury
has been found to cause memory loss by inactivating enzymes necessary for brain
cell energy production and proper assembly of the protein tubulin into
microtubules(
258). DMSO has been found to have
some capability to repair such
damage(
581).
III.
Treatment of Toxic Related Neurological Conditions
The mechanisms by which mercury causes
neurological conditions
have
been documented, but it
has also been found that people with such conditions commonly recover or have
significant improvement after amalgam replacement- from conditions including:
memory
disorders (8,35,94,212,222,322,440,453,552,557,581,582), schizophrenia and
bipolar disorder(294,295,465,560,581,34,35), depression
(62,94,107,163,185,212,222,229,233bcfh,271,294,285e,317,322,376,
386de,453,465,485,523,525c,532,538,551,556,557,581,582,35,40), insomnia
(35,62,94,212,222,233ag,271,317,322,376,525c,581,582),
anger(212,233,102,557,35,62), anxiety & mental confusion
(62,94,212,222,229,233abcfgh,271,317,322,440,453,525c,532,551,557, 581,35,57),
neuropathy/paresthesia (8,35,62,94,163,212,222,322,556,557,581,582),
MS(62,94,95,102,163,170,212,222,229,271,291,302,322,369,469,485,34,
35c,229,523,532,581), ALS(97,423,405,469,470,485,535,35), Parkinson’s/
muscle tremor (222,248,228a,229,233f, 271,322,469,535,557,581,582, 212,62,94,
98,35), Alzheimer’s(62,204,251c,386e,535,581,35),
headaches/migraines
(5,8,34,35,47f,62,95,185,212ab,222,229, 233abdefgh,271,317,322,349,
354,115,376,440,453, 523,525,532,537,538, 552,556,581,582,583
), epilepsy
(5,35,309,229,386e,557,581), ataxia/balance
problems (250c,581,582);
Lipoic acid has been found to have
protective effects against cerebral
ischemic-reperfusion
,
excitotoxic amino acid(glutamate) brain injury, mitochondrial dysfunction,
diabetic neuropathy (572,550). Other antioxidants such as carnosine
(495a), Coenzyme Q10, Vitamins C & E, ginkgo biloba,
pycnogenol
and selenium have also been found protective against degenerative neurological
conditions and ginkgo biloba and 5-HTP for
ADHD( 176,494,495
e,444,237,550,20). Several
doctors have found thiamin(B3), Vit B6, inositol, and folic acid
supplementation to alleviate peripheral neuropathies, pain, tinnitus, and other
neurological conditions (502). Several studies have documented that
lipoic
acid(
an antioxidant and chelator) resulted in
improvement in the majority of diabetes cases it was used for, by improving
glucose metabolism, increasing insulin sensitivity, and reducing nerve
damage(including in diabetic neuropathy)(501e,550).Properly formulated
nutritional treatments have been found to be effective in treating ADHD
and depression(522). Hormonal imbalances such as from
taking birth control pills can be a factor in causing B vitamin deficiencies
such as B6 and Riboflavin which can be a factor in migraine
headaches. Supplementation has been found to be helpful in
such circumstances (20).
Some confirmed Neurological
Conditions caused by Gluten or Milk Casein or the
toxic metal effect on them
include Autism, ADHD, Neuropathy, Ataxia, Multiple Sclerosis, Allergy, Autoimmune
Disease (4).
Effective Natural Treatments of ADHD
Saffron
improved ADHD symptoms as much as Ritalin
, and more beneficial to better
sleep.
6
Multiple studies show supplemental EPA/DHA from fish and algae
oils boost focus and attention in those with ADHD.3
Zinc
: Up to 30%
of ADHD kids have zinc deficiencies. Supplementing zinc reduces hyperactivity
and enhances social and behavioral function.
5
A study found vitamin C and EFA supplementation significantly improved ADHD outcomes. 7
Magnesium
aids
nervous system function. Combined with omega-3s in one study, magnesium leads
to significant ADHD symptom improvement.
9
Ginkgo Biloba : Multiple studies show the botanical Ginkgo biloba enhances attention an d alleviates hyperactivity. 10
Pine Bark Extract
:
By reducing oxidative stress, pine bark extract improves focus, attention and
behavior in those with ADHD based on studies.
12
Chamomile
:
Research indicates the chamomile herb significantly improves inattention and
hyperactivity.
13
Iron
:
Up to 30% of ADHD
children have low iron stores, which are essential for dopamine activity. Iron
supplements effectively reduce symptoms.
8
One chelation expert (581)
suggests when chelating with DMPS supplementation with a good
multivitamin/multimineral plus Vit
E(
400 IU),
selenium(200-400 ug), and Vit C(=>2 grams or Vit C IV) (581). He
also finds chlorella beneficial for most. He has found that other
factors that reduce detoxification include:
Low sodium, calcium, potassium, or
selenium levels
Low protein in diet or low stomach acid
Hormonal problems
Low serum cholesterol (carrier)
Low glutathione or other detox enzymes
Kidney problems or damage from mother’s
amalgams
Constipation or Leaky Gut
Electromagnetic
influences(
scars,
Geopathic Stress, EMF, RF waves)
For
information and treatment of factors involved in neurological conditions other
than toxic metals, see the treatment section of the individual condition review
paper of interest, linked above.
References:
(
2)U.S.
Environmental Protection Agency(EPA), 1999, "Integrated Risk
Information System, National Center for Environmental
Assessment, Cincinnati, Ohio,
http://www.epa.gov/ncea/iris.htm
(3)
Marlowe M et al, “Main and interactive effects of metallic toxins on classroom
behavior”, J Abnormal Child Psychol, 1985, 13(2):185-98; & Moon C et al,
“Main and Interactive Effect of Metallic Pollutants on Cognitive Functioning”,
Journal of Learning Disabilities, April, 1985; & Pihl RO et al,
“Hair element content in Learning Disabled Children”, Science, Vol 198, 1977,
204-6; &
Gowdy
JM et al, “Whole blood mercury in
mental hospital patients”, Am J Psychiatry, 1978, 135(1):115-7.
(4)
Confirmed
Adverse Health Effects of Glutens
Lymphoma, Thrombosis, Myocarditis,
Diabetes, Autism, Neuropathy, Ataxia, Multiple Sclerosis, Allergy, Asthma, Autoimmune
Disease, Dermatitis, Thyroiditis, Obesity, Hepatitis, Arthritis, Osteoporosis, Anemia,
Infertility, Autoimmunity, Nephropathy, Renal Disease, Uveitis, Colitis, Crohn
Disease, Pancreatitis, Psychosis)
(5)
D.Klinghardt
(MD), “Migraines,
Seizures, and Mercury Toxicity”, Future Medicine
Publishing,1997;&
Migraines, Seizures, and Mercury
Toxicity;
Klinghardt
D. Alternative Medicine
Magazine ,Issue
21 Dec,1997/Jan,1998.
www.healingartscenter.com/Library/articles/art10.htm
& (b)
Klinghardt
D; A
series
of fibromyalgia cases treated for heavy metal toxicity: case report and
hypothesis; Journal of
Orthopaedic
Medicine 2001 23 58-59
(8)
Redhe,O
.
Sick
From Amalgam
R-Dental Ab,
Frejavagen
33,
S-79133 Falun, Sweden (100 cases
).
Olle
Redhe
; [olle.redhe@telia.com]
(9)(a)
Dr.I.Gerhard
, Dr.
E.Roller,et
al, Tubingen Univ. Gynecological
Clinic, Heidelberg,1996; & (b)Gerhard I, Monga
B,
Waldbrenner
A,
Runnebaum
B “Heavy Metals and Fertility”, J of Toxicology and Environmental
Health,Part
A, 54(8):593-611, 1998; & (c) Gerhard I,
Waibel S, Daniel V,
Runnebaum
B “Impact of heavy metals on hormonal and immunological
factors in women with repeated miscarriages”, Hum
Reprod
Update 1998 May;4(3):301‑309; & (d) Gerhard I, “
Ganzheitiche
Diagnostik
un
Therapie
bie
Infertilitat
”, Erfahrungsheilkunde,1993,
42(3): 100-106; & (e)“Hormonal conditions affecting women caused by
environmental poisons” in
Pravention
, Diagnose und
Therapie
von
Umwelterkrankungen
,
JD Kruse-
Jarres
(Ed.), 1993,
p51-68; & (f) Gerhard
I,
Waldbrenner
P,
Thuro
H,
Runnebaum
B, Diagnosis of heavy metal loading by the oral
DMPS and chewing gum tests.
Klinisches
Labor 1992,
38:404-411.
(12)
a) Dr Russell Blaylock, Wellness Report,
Carnitine Compounds Protect against Aging, July 2022, V
19,N
7;
&(b) Why is the Incidence of Brain Degeneration Increasing?, Wellness
Report, Vol. 20, No.5
& (c) Excitotoxicity is a
significant factor in brain inflammation and degeneration, Russell Blaylock,
MD; www.russellblaylockmd.com
(13)(a)
S.Hussain
et al, “Mercuric chloride‑induced reactive oxygen species and its effect on
antioxidant enzymes in different regions of rat
brain”,J
Environ
Sci Health B 1997 May;32(3):395‑409; &
P.Bulat
,
“Activity of
Gpx
and SOD in workers occupationally
exposed to mercury”, Arch
Occup
Environ Health, 1998,
Sept, 71 Suppl:S37-9; &
Stohs
SJ, Bagchi D. Oxidative mechanisms in the
toxicity of metal ions. Free
Radic
Biol
Med 1995; 18(2): 321-
36 ;
&
D.Jay
, “Glutathione inhibits SOD activity of Hg”, Arch Inst
cardiol
Mex,
1998,68(6):457-61 &(b)
S.Tan
et al,
“Oxidative stress induces programmed cell death in neuronal cells”, J
Neurochem
, 1998, 71(1):95-105; & Matsuda T, Takuma K,
Lee E, et al. Apoptosis of
astroglial
cells
[
Article in Japanese]
Nippon
Yakurigaku
Zasshi
.
1998 Oct;112 Suppl 1:24P-
; &
Lee
YW, Ha MS, Kim YK.. Role of reactive oxygen species and
glutathione in inorganic mercury-induced injury in human glioma
cells.
Neurochem
Res. 2001
Nov;26(11):1187-93. & (c)Ho PI, Ortiz D, Rogers E,
Shea TB. Multiple aspects of homocysteine neurotoxicity: glutamate
excitotoxicity, kinase hyperactivation
and DNA damage. J
Neurosci
Res. 2002 Dec 1;70(5):694-702; & (d)
Pizzichini
M
et al, Influence of amalgam fillings on Hg levels and total antioxidant
activity in plasma of healthy
donars
. Sci
Total Environ 2003, 301(1-3):43-50; & (e) Metals, toxicity and
oxidative stress.
Valko
M, Morris
H, Cronin MT. Curr Med Chem. 2005;12(10):1161-208.
(19) Matts
Hanson. Dept
of Zoophysiology
, University
of Lund, Sweden. “Amalgam hazards in your teeth
”, J.
Orthomolecular Psychiatry 1983; 2(3):
194-201; &
F.L.Lorscheider
et al, “Evaluation of the safety issue of mercury release from amalgam
fillings”, 1993, FASEB J, 7:1432-33; & b
Momoi
Y,
et al; Measurement of galvanic current and electrical potential in extracted
human teeth”, J Dent Res, 65(12): 1441-1444; & Holland RI, Galvanic
currents between gold and amalgam.
Scand
J
Dent Res, 1980,88:269-72; & Wang Chen CP and Greener EH, A galvanic study
of different amalgams, Journal of Oral Rehabilitation, 1977, 4:23-7; &
Lemons JE et al, intraoral corrosion resulting from coupling dental implants
and restorative metallic systems, Implant Dent, 1992, 1(2):107-112
(20)
The
24 Hour
Pharmacist
, S. Cohen, Rodale Books,
2007.
(21)
R.
A.
Goyer
,”Toxic effects of
metals”in
:
Caserett
and Doull’s
Toxicology-
TheBasic
Science
of Poisons
, McGraw-Hill Inc., N.Y., 1993; &(b) Goodman, Gillman, The
Pharmacological Basis of Therapeutics, Mac Millan Publishing Company, N.Y.
1985; &(c) Encyclopedia of
Occumpational
Health
and Safety, International
Labour
Office, Geneva, Vol
2, 3rd Edition.;&(d) Arena, Drew, Poisoning. Fifth
Edition. Toxicology-Symptoms-Treatment, Charles C.
Thomas-Publisher, Springfield, Il1986.
(27)
Matts Hanson.” Why is Mercury
toxic?:
Basic
chemical and biochemical properties of Mercury/amalgam in relation to
biological effects”. ICBM conference Colorado Springs, Co,
1988, Proceedings
;
&(b) Hartman DE. Missed diagnoses and misdiagnoses of
environmental toxicant exposure, MCS.
Psychiatr
Clin North Am 1998,
21(3):659-70. & (c) Merritt’s Textbook
of Neurology, 9th Ed., Williams and Wilkins, Baltimore, 1995, p668-,
&
Clinical Management of Poisoning
, 3rd Ed.,(p753) Haddad,
Shannon, and Winchester, W.B. Saunders and Company, Philadelphia, 1998;
&(d) National Human Adipose Tissue Survey FY82, EPA-560/5-86-039,
Dec.1986; *EPA Report: 100% Of Human Adipose Fat
Samples Studied Are Laced With Chlorinated Solvents and Heavy
Metals www.health‑doc.com/healtharticles/bftoxicityreport.html
(32)
T.
A.Cook
et al, “Fatal mercury
intoxication in a dental surgery assistant”, British Dent
Journal, 1969, 127:533-555.
(33)
(a) Markovich et al, "Heavy metals
(
Hg,Cd
) inhibit the activity of the liver and kidney
sulfate transporter Sat‑1",
Toxicol
Appl
Pharmacol
, 1999,154(2):181‑7;
& (b)2S.A.McFadden, “Xenobiotic metabolism and adverse environmental
response: sulfur-dependent detox
pathways”,Toxicology
,
1996, 111(1-3):43-65; &(c) S.C. Langley-Evans et al, “SO2: a
potent
glutathion
depleting agent”, Comp
Biochem
Physiol
Pharmocol
Toxicol
Endocrinol, 114(2):89-98; & (d)Alberti A,
Pirrone
P, Elia M, Waring RH, Romano
C. Sulphation deficit in “
low-functioning
”
autistic children. Biol Psychiatry 1999, 46(3):420-4.
(34)
PatrickStörtebecker,Associate
Professor
of Neurology, Karolinska Institute, Stockholm.
Mercury Poisoning
from Dental amalgam-A Hazard to the Human Brains
, ISBN: 0-941011001-
1 &
Dental Caries as
a Cause of Nervous Disorders,
Bioprobe.Inc.,http://www.bioprobe.com; &
Neurology
for Barefoot
Doctors,
Stortebecker
Foundation for Research,
1988: & J Canadian Dental Assoc, 33(6): 300-;& (b)
Henriksson
J,
Tjalve
H. Uptake of inorganic mercury
in the olfactory bulbs via olfactory pathways in rats. Environ
Res. 1998 May;77(2):130-
40..
(35) (a)Huggins
HA,
Levy,TE
,
Uniformed Consent: the hidden
dangers in dental care
, 1999, Hampton Roads Publishing Company
Inc; & (b) Hal Huggins,
Its
All in Your Head,
1997; & (c) Huggins, HA,
Solving
the MS Mystery: Help, hope and recovery
, 2002; &(d) Toxic Elements
Research Foundation, Colorado Springs Colorado, “
Survery
of 1320 patients being treated for heavy metal toxicity”,
2001. 800-331-2303; &
(e)Center
for Progressive Medicine,
1999, http://www.hugnet.com
(36) Sam
Queen;
Chronic Mercury Toxicity
- New
Hope Against
an
Endemic Disease. http://www.bioprobe.com; &
F.
L.Lorscheider
et al, "Mercury exposure from
silver tooth fillings: emerging evidence questions a paradigm", FASEB J
9:504-508,1995.
(38)
S.Ziff
and
M.Ziff
, Infertility
and
Birth Defects: Is Mercury from Dental Fillings a Hidden Cause?,
Bio-Probe,
Inc. ISBN: 0-941011-03-8.1987
(39
)
M.Inouye
et al, Behavioral and
neuropathological effects of prenatal methyl mercury
exposure in mice”.
Neurobehav.Toxicol
Teratol
., 1985
:7;227‑232; &(b)
Z.Annau
et al, Johns Hopkins Univ., School
of Public Health, “Mechanisms of neurotoxicity and their relationships to
behavioral changes”, Toxicology, 1988, 49(2): 219-25; &(c) Vinay SD, Sood
PP. Inability of thiol compounds to restore CNS arylsulfatases
inhibited by methyl mercury.
Pharmacol
Toxicol
1991 Jul;69(1):71-
4;&
(d)
P.Grandjean
et al, “
MeHg
and
neurotoxicity in children”, Am J Epidemiol, 1999,
150(3):301-5: &(e) Budtz-Jorgensen E,
Grandjean
P,
Keiding
N, White RF,
Weihe
P. Benchmark dose calculations of
methylmercury-associated neurobehavioral deficits.
Toxicol
Lett 2000 Mar 15;112-113:193
- ;
& (f) Crump KS,
Kjellstrom
T, Shipp AM, Silvers A, Stewart A. Influence of
prenatal mercury exposure upon scholastic and psychological test performance:
benchmark analysis of a New Zealand cohort. Risk Anal 1998
Dec;18(6):701-13; &(g)
Grandjean
P,
Weihe
P, Murata K, Sorensen N, Dahl R, Jorgensen
PJ. Cognitive deficit in 7-year-old children with prenatal exposure to
methylmercury.
Neurotoxicol
Teratol
1997 Nov-Dec;19(6):417-28; & (h) More evidence of mercury effects in
children;
Environ
Health
Perspect
. 1999 Nov;107(11
):A
554-5;
& Epidemiology July
1999;10:370-375; & (
i
) [Environmental
epidemiology research leads to a decrease of the exposure limit for
mercury] [Article in Danish]
Weihe
P,
Debes
F, White RF, Sorensen
N, Budtz-Jorgensen E,
Keiding
N,
Grandjean
P.
Ugeskr
Laeger
. 2003 Jan 6;165(2):107-11.
(40)
F.Perger
,
Amalgamtherape
,
in
Kompendiu
der
Regulationspathologie
und
Therapie
, Sonntag-Verlag, 1990;
& “
Belastungen
durch
toxische
Schwermetalle
”, 1993, 87(2): 157-63; &
K.H.Friese
, ”
Homoopathische
Behandlung
der
Amalgamvergiftung
”,
Allg
.
Homoopathische
Z, 241(5);
184-187, &
Erfahrungsheikunde
, 1996, (4):
251- 253; & “
Amalgamvergiftung_moglicher”Der
Naturazt,1995,135(8):13-15; & “
Schnupfen
-Was
tun?”,
Therapeutikon
, 1994,
8(3): 62-68;&
Homoopathische
Behandlung
de
Amalgamvergiftung
& “
Polemik
und
Wirklichkeit
”, Allgemeine
Homoopathische
zeitschrift
, 1994,
239(6): 225-233 ; & “
Amalgamtherapie
fur
Arzte
und
Zahnarzte
”,
Panta
3, 1992,
Haug
-Verlag.;
& Natura Med 1992, 7(4): 295-306; &
M.Strassburg
et al, “Generalized
allergic reaction from silver amalgam fillings”,
Dtsche
Zahnarztliche
Zeit,
22:3-9, 1967.(
total:over
1200 cases)
(43)
(
a)Knapp LT;
Klann
E. Superoxide‑induced stimulation of protein kinase C
via thiol
modification and modulation of
zinc content. J Biol Chem 2000 May 22; &
P.Jenner
,“Oxidative
mechanisms in PD”, Mov
Disord
, 1998; 13(Supp1):24-34; &
Offen
D, et al;. Antibodies from ALS patients inhibit
dopamine release mediated by L-type calcium channels. Neurology 1998
Oct;51(4):1100-3. &(b)
B.Rajanna
et
al, “Modulation of protein kinase C by heavy metals”,
Toxicol
Lett, 1995, 81(2-3):197-203:
&
A.Badou
et al, “HgCl2-induced IL-4 gene expression in T
cells involves a protein kinase C-dependent calcium influx through L-type
calcium
channels”J
Biol Chem. 1997 Dec
19;272(51):32411-8., &
D.B.Veprintsev
, 1996,
Institute for Biological Instrumentation, Russian Academy of
Sciences, Pb2+ and Hg2+ binding to alpha‑lactalbumin”.
Biochem
Mol Biol Int 1996 Aug;39(6):1255‑65; & M. J.
McCabe, University of Rochester School of Medicine & Dentistry, 2002,
Mechanisms of Immunomodulation by Metals,
www2.envmed.rochester.edu/envmed/TOX/faculty/mccabe.html;
(48)
K.
Arvidson
,”Corrosion studies of
dental gold alloy in contact with amalgam”, Swed. Dent.
J 68: 135-139,1984; & Skinner, EW,
The Science of
Dental Materials
, 4th
Ed.revised
,
W.B.Saunders
Co., Philadelphia, p284-285,1957; &
Schoonover IC, Souder W. Corrosion of dental
alloys. JADA, 1941, 28: 1278-91.
(49) Kingman
A, Albertini T, Brown LJ. National Institute of Dental Research,
“Mercury concentrations in urine and blood associated with amalgam exposure in
the
U.
S.military
population”, J Dent Res. 1998 Mar;77(3):461-71.
(50)
(
a)Sin YM,
Teh
WF, Wong MK, Reddy PK - "Effect of Mercury on Glutathione and Thyroid
Hormones" Bulletin of Environmental Contamination and Toxicology
44(4):616-622 (1990); & (b)
J.Kawada
et al,
“Effects of inorganic and methyl
mercury on thyroidal
function”, J
Pharmacobiodyn
, 1980, 3(3):149-59;
&(c) Ghosh N.
Thyrotoxicity
of cadmium
and mercury. Biomed
Environ Sci 1992, 5(3): 236-40; & (d)Goldman, Blackburn, The Effect of
Mercuric Chloride on Thyroid Function of the Rat,
Toxicol
and Applied Pharm 1979, 48: 49-55; &(e)Kabuto M - "Chronic effects of
methylmercury on the urinary excretion of catecholamines and their responses to
hypoglycemic stress" Arch
Toxicol
65(2):164-7
(1991
) ;
& Assoc. for Birth Defect
Children,Birth
Defect News, March 2001;
(51)
Heintze
et
al,“
Methylation
of Mercury from dental amalgam and mercuric chloride by
oral
Streptococci”.,Scan
. J. Dent. Res. 1983, 91:150‑152:
& Rowland
, Grasso, Davies “The
Methylation of Mercuric Chloride by Human Intestinal
Bacteria”.
Experientia
. Basel 1975
,31: 1064‑1065; &
M.
K.Hamdy
et al, “Formation of methyl mercury by bacteria”, App
Microbiol
,
1975, Sept.; &
W.Forth
, “
Toxikologie
von
Quecksilberverbindungen
”, in
Quecksilber
in der Umwelt-Hearing
zur
Amalgamprolematik
,
Niedersachsisches
Umweltministerium
,
1991; & Brun A, Abdulla M,
Ihse
I, Samuelsson
B. Uptake and localization of mercury in the brain of rats after
prolonged oral feeding with mercuric
chloride. Histochemistry. 1976 Apr 21;47(1):23-9; &
Ludwicki
JK Studies on the role of gastrointestinal tract
contents in the methylation of inorganic mercury compounds Bull Env
Contam
Toxicol
42 1989 283-288;
& Choi SC, Bartha
R..
Cobalamin-mediated
mercury methylation by
Desulfovibrio
desulfuricans
LS. Appl Environ
Microbiol
. 1993 Jan;59(1):290-5; & Wang J, Liu Z;
[.In
vitro Study of
Strepcoccus
Mutans in the Plaque on the Surface of Amalgam Fillings on the
Convertion
of Inorganic Mercury to Organic Mercury][Article
in Chinese], Shanghai Kou
Qiang
Yi Xue. 2000
Jun;9(2):70-2.
(52) Szasz A,
Barna
B,
Gajda
Z,
Galbacs
G, Kirsch-
Volders
M,
Szente
M. Effects of continuous low-dose
exposure to organic and inorganic mercury during development on
epileptogenicity in
rats.Neurotoxicology
. 2002
Jul;23(2):197-206. szente@bio.u-szeged.hu
(56)(a)
A.Nicole
et al, “Direct evidence for glutathione as
mediator of apoptosis in neuronal cells”, Biomed
Pharmacother
,
1998; 52(9):349-55; &
J.P.Spencer
et al,
“Cysteine & GSH in PD”, mechanisms involving ROS”, J
Neurochem
,
1998, 71(5):2112-22: & & J.S. Bains
et al, “Neurodegenerative disorders in humans and role of glutathione in
oxidative stress mediated neuronal death”, Brain Res Rev, 1997,
25(3):335-58;&
Medina S, Martinez M,
Hernanz
A,
Antioxidants
inhibit the human cortical neuron apoptosis induced by hydrogen peroxide, tumor
necrosis factor alpha, dopamine and beta-amyloid peptide
1-42.. Free
Radic
Res. 2002
Nov;36(11):1179-84. &(
b)
D.
Offen
et al, “Use of thiols in treatment of PD”, Exp
Neurol, 1996,141(1):32-9; &
Pocernich
CB, et al. Glutathione elevation and its protective role in
acrolein-induced protein damage in
synaptosomal
membranes: relevance to brain lipid peroxidation in neurodegenerative disease.
Neurochem
Int 2001 Aug;39(2):141-9; & (c
) Pearce
RK, Owen A, Daniel S, Jenner P, Marsden
CD. Alterations in the distribution of glutathione in the substantia nigra
in Parkinson's disease. J Neural
Transm
. 1997;104(6-7):661-77;
&
A.D.Owen
et al, Ann NY
Acad
Sci, 1996, 786:217-33; & JJ
Heales
et al,
Neurochem
Res, 1996, 21(1):35-39; & &
X.M.Shen
et al, Neurobehavioral effects of NAC conjugates
of dopamine: possible relevance for
Parkinson’sDisease
”, Chem
Res
Toxicol
, 1996, 9(7):1117-26; & Chem Res
Toxicol
, 1998, 11(7):824-37; & (d) Li H,
Shen XM,
Dryhurst
G. Brain
mitochondria catalyze the oxidation of
7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid
(DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge
glutathione: potential relevance to the pathogenesis of Parkinson's
disease. J
Neurochem
. 1998
Nov;71(5):2049-62; & (e)
Araragi
S, Sato M. et
al, Mercuric chloride induces apoptosis via a mitochondrial-dependent pathway
in human leukemia cells. Toxicology. 2003 Feb 14;184(1):1-9.
(57)
N.Campbell
&
M.Godfrey,“Confirmation
of Mercury Retention and Toxicity
using DMPS provocation” ,J of Advancement in Medicine, 7(1) 1994;(80
cases); & (b)
D.Zander
et
al, “Mercury mobilization by DMPS in subjects with and without
amalgams”,
Zentralbl
Hyg
Umweltmed
, 1992, 192(5): 447-54(12
cases);
(60)
V.D.
M.Stejskal
, Dept. Of Clinical
Chemistry, Karolinska
Institute, Stockholm, Sweden LYMPHOCYTE IMMUNO‑STIMULATION
ASSAY ‑
MELISA” &
VDM Stejskal et
al, "MELISA: tool for the study of metal allergy", Toxicology in
Vitro, 8(5):991-1000, 1994; & (c) Stejskal V. Immunological effects of
amalgam components: MELISA—a new test for the diagnosis of mercury
allergy. Proceedings of the International Symposium Status Quo and
Perspectives of Amalgam and other Dental Materials; April 29–May 14,
1994;
Otzenhausen
, Germany. http://www.melisa.org
(61)
E.Lutz
et al, “Concentrations of
mercury in brain and kidney of fetuses and infants”, Journal of Trace Elements
in Medicine and Biology, 1996,10:61-67; &
G.Drasch
et al, “Mercury Burden of Human Fetal and Infant
Tissues”,
Eur
J
Pediatr
153:607-610,1994;
(62) Dr. J.E. Hardy,
Mercury
Free: the wisdom behind the growing consumer
moverment
to ban silver dental fillings
,
1998.
(66) “Regional
brain trace‑element studies in Alzheimer’s disease”.
C.
MThompson,W.R
.
Markesbery
, et al,
Univ. Of Kentucky Dept. Of Chemistry, Neurotoxicology (1988
Spring) 9
(1):1‑7 & Hock et al,
“Increased blood mercury levels in Alzheimer’s patients”,
Neural.
Transm
.
1998, 105
:59-68
& Cornett et al, “Imbalances of trace elements related to oxidative damage
in Alzheimer’s
diseased
brain”,
Neurotoxicolgy,1998, 19:339-345.
(67) A search for
longitudinal variations in trace element levels in nails of Alzheimer’s disease
patients. Vance DE Ehmann WD
Markesbery
WR In: Biol
Trace Elem Res (1990 Jul‑Dec)26‑27:461‑70; & Ehmann et al, 1986,
Neurotoxicology,
7:195-206;
& Thompson et al, 1988, Neurotoxicology, 9:1-7.
(68)
K.
A.Ritchie
et al, Univ. Of
Glasgow,"Psychomotor
testing of dentists with chronic
low level mercury exposure
", J
Dent
Res 74:420, IADR Abstract 160(1995): &
Occup
Environ Med, 1995, 52(12): 813-7
(69) D
Gonzalez-Ramirez et al; "
Uninary
mercury,
porphyrins, and neurobehavioral changes of dental workers
in Monterrey, Mexico”, J
Pharmocology
and
Experimental Therapeutics, 272(1): 264-274,1995
(70)
D.Echeverria
et al,
Batelle
Center for Public Health Research, Seattle,
"Behavioral Effects of Low Level Exposure to Hg vapor Among
Dentists", Neurotoxicology & Teratology;
17(2):161-168(1995);
(71)
S.C.Foo
et al, "Neurobehavioral effects in
Occupational Chemical
Exposure", Environmental Research, 60(2):
267-273, 1993; &(b) D.G.
Mantyla
et al,
"Mercury toxicity in the dental office: a neglected problem",
JADA, 92:1189-1194, 1976; & A case of mercury contamination of a
dental suite, JADA, 1976, Vol 92; &(d) Symington D, Mercury
poisoning in dentists, J Soc
Occup
Med, 1980,
30:37-39; & (e) Mercury intoxication resulting from school barometers in
three unrelated adolescents,
Koyun
M,
Akman
S,
Güven
AG.
Eur
J
Pediatr
. 2004
, Mar;163(3):131-4; & (f)
Subclinical
inorganic mercury neuropathy: Neurophysiological investigations in 17
occupationally exposed subjects,
The Italian Journal of
Neurological Sciences
.
Volume 8, Number 3 / June,
1987
,
Zampollo
A. et
al.
(84)
J.C.Veltman
et al, “Alterations of heme, cytochrome P-450,
and steroid metabolism by mercury in rat adrenal gland”, Arch
Biochem
Biophys
, 1986,
248(2):467-78; &
A.G.Riedl
et al,
Neurodegenerative Disease Research Center, King’s College, UK, “P450 and
hemeoxygenase
enzymes in the basal ganglia and their
role’s
in Parkinson’s disease”, Adv Neurol, 1999;
80:271-86; & Alfred V.
Zamm
. Dental Mercury: A Factor that Aggravates and
Induces Xenobiotic
Intolerance. J.
Orthmol
. Med. v6#2 pp67-77 (1991).
(94)
F.Berglund
,
Case reports
spanning 150 years on the adverse effects of dental
amalgam
,
Bio-Probe, Inc.,Orlando,Fl,1995;ISBN 0-9410011-14-3(245
cured); & Tuthill JY, "Mercurial neurosis
resulting from amalgam fillings", The Brooklyn Medical Journal, December
1898, v.12, n.12, p725-742
(97)
Redhe
O,
Pleva
J, "Recovery
from ALS and from asthma after removal of dental amalgam
fillings", Int J Risk & Safety in Med 1994; 4:229-
236,
& Adams
CR, Ziegler DK, Lin JT., “Mercury intoxication simulating ALS”, JAMA,
1983, 250(5):642-5;
(98)
A.Seidler
et al, Possible
environmental factors for Parkinson's
disease",Neurology
46(5): 1275- 1284,
1996; & Vroom FO, Greer
M, "Mercury vapor
intoxication", 95: 305-318, 1972;
& Ohlson
et al, “Parkinson’s Disease and Occupational Exposure to
Mercury”,
Scand
J. Of
Work Environment
Health, Vol7, No.4: 252-256, 1981; L.G.
Golota
,
“Therapeutic properties of
Unitihiol
” Farm.
Zh
. 1980, 1: 18-22.
(99) M.
Nylander et al, Mercury accumulation in tissues from dental staff
and controls
”, Swedish Dental Journal,
13:235-243, 1989; & M. Nylander et
al,Mercury
and selenium concentrations and their
interrelations in organs from dental staff and the general
population. Br J Ind Med 1991, 48(11):729-
34;
& “Mercury
in pituitary glands of dentists”, Lancet,442, Feb 26, 1986.
(102) R.L.
Siblerud
et
al,"Evidence
that mercury from silver fillings may be an etiological factor in multiple
sclerosis", Sci Total Environ, 1994, 142(3):191-
205 ,
&
“Mental health, amalgam fillings, and MS”, Psychol Rep,1992, 70(3 Pt2),
1139-51;&
Siblerud
R.L. and Kienholz E. Evidence
That Mercury From Dental Amalgam May Cause
Hearomg
Loss In Multiple Sclerosis
Patoemts
. J.
Orthomol
. Med, v12#4 pp 240-4 (1997); &
R.
L.Siblerud
, “A
commparison
of mental health of multiple
schlerosis
patients with silver dental fillings
and those with fillings
removed”, Psychol Rep, 1992, 70(3),Pt2, 1139-51.
(104)
C.
F.Facemire
et al, “Reproductive
impairment in the Florida Panther”, Health Perspect,1995, 103 (Supp4):79-86;
&
J.M.Yang
et al, “The distribution of HgCl2 in
rat body and its effect on fetus”, Environ Sci , 1996, 9(4): 437-42; & Rao
MV, Sharma PS. Protective effect of vitamin E against mercuric
chloride reproductive toxicity in male mice.
Reprod
Toxicol
. 2001
Nov;15(6):705-12; &
Monsees
TK, Franz M, Gebhardt
S,
Winterstein
U,
Schill
WB,
Hayatpour
J. Sertoli cells as a target
for reproductive hazards.
Andrologia
. 2000
Sep;32(4-5):239-46; &
M.Maretta
et al, “Effect of mercury on the epithelium
of the fowl testis”, Vet Hung 1995, 43(1):153-6; &
Orisakwe
OE,
Afonne
OJ,
Low-dose
mercury
induces
testicular
damage
in
mice
that
is
protected
against
by
zinc.Eur
J
Obstet
Gynecol
Reprod
Biol. 2001 Mar;95(1):92-6
(105)
T.Colborn
(Ed.),
Chemically Induced Alterations in
Functional Development
, Princeton Scientific
Press,1992; & ” Developmental
Effects of Endocrine-Disrupting
Chemicals",Environ
Heath Perspectives, V 101, No.5, Oct 1993; &
B.Windham
,
"Health, Hormonal, and Reproductive Effects of Endocrine Disrupting
Chemicals" (including mercury), Annotated Bibliography
,1996
www.flcv.com/endocrin.html
; &
Giwercman
A, Carlsen E,
Keiding
N,
Skakkabaek
NE, Evidence for increasing incidence
of abnormalities of the human testis: a review. Environ Health
Perspect
1993; 101
Suppl(
2):
65-71; & Trachtenberg IM,
Chronic effects of mercury in organisms.
U.S. Dept.
Of Health, Education, and Welfare,
Publ
74-473,
1974,
(107)
R.
L.Siblerud
et
al,”Psychometric
evidence that mercury from dental fillings
may be a factor in
depression,anger,and
anxiety",
Psychol Rep, v74,n1,1994; & Amer. J. Of Psychotherapy, 1989; 58:
575-87;
Poisoning and Toxicology
compendium
,Leikin
&
Palouchek
, Lexi-Comp,1998,p705
(108)
M.Henningsson
et
al,"Defensive
characteristics in individuals with
amalgam illness",
Acta
Odont
Scand
54(3): 176-181,1996.
(109) Y.X.
Liang et
al,"Psychological
effects of low
exposure to mercury
vapor
",Environmental
Med
Research, 60(2): 320-327, 1993; &
T.Kampe
et al, "Personality traits of
adolescents with intact and repaired
dentitions",Acta
Odont
Scand,44:95-,1986; &
R.Kishi
et al, Residual neurobehavioral effects of chronic exposure to mercury vapor”,
Occupat
.
Envir
. Med.,
1994, 51:35-
41;&
A.Sikora
et al, “Evaluation of mental functions in workers exposed to metallic mercury”,
Med
Pr
, 1992, 43(2):109-21..
(110)
N.Roeleveld
et al, "Mental
retardation and parental occupation", Br J Ind Med
50(10): 945-954, 1993.
(111) (a)
Quig
D, Doctors Data
Lab,"
Cysteine
metabolism
and metal toxicity", Altern Med
Rev, 1998;3:4, p262‑270, &
(b) J.de
Ceaurriz
et al, Role
of gamma‑
glutamyltraspeptidase
(GGC) and
extracellular glutathione in
dissipation of inorganic
mercury",J
Appl
Toxicol,1994, 14(3): 201‑; & W.O. Berndt et
al,
"Renal
glutathione and
mercury uptake",
Fundam
Appl
Toxicol
,
1985, 5(5):832‑9; &
Zalups
RK,
Barfuss
DW. Accumulation and handling of
inorganic mercury in the kidney after coadministration with glutathione,
J
Toxicol
Environ Health,
1995, 44(4): 385-99; &
T.
W.Clarkson
et al, "
Billiary
secretion of glutathione‑metal complexes",
Fundam
Appl
Toxicol
,
1985, 5(5):816‑31;
(114)
M.Aschner
et al, “Metallothionein
induction in fetal rat brain by in utero exposure to elemental mercury
vapor”,
Brain Research, 1997, dec 5, 778(1):222-32;
&
Aschner
M, Rising L, Mullaney
KJ. Differential sensitivity of neonatal rat astrocyte
cultures to mercuric chloride (MC) and methylmercury (
MeHg
):
studies on K+ and amino acid transport and metallothionein (MT)
induction. Neurotoxicology. 1996 Spring;17(1):107-16.
& T.V. O’Halloran, “Transition metals in control of gene expression”,
Science, 1993, 261(5122):715-25; & Matts RL, Schatz JR, Hurst R,
Kagen
R. Toxic heavy metal ions inhibit
reduction of disulfide bonds. J Biol Chem 1991; 266(19): 12695-702;
Boot JH. Effects of SH-blocking compounds on the energy metabolism
in isolated rat hepatocytes. Cell Struct
Funct
1995; 20(3): 233-
8;
&
Baauweegers
HG, Troost D. Localization of
metallothionein in the
mammilian
central nervous
system..
Biol Signals 1994, 3:181-7.
(119) (
a)
L.Ronnback
et al, "Chronic
encephalopaties
induced by low doses of mercury or lead", Br J Ind Med
49: 233-240, 1992; &(b)
H.Langauer‑Lewowicka
,”
Changes in the nervous system due to occupational metallic mercury poisoning”
Neurol
Neurochir
Pol 1997 Sep‑Oct;31(5):905‑13;
&(c)
Langauer-Lewowicka
H. [Chronic
toxic
encephalopathies]
[Polish] Med
Pr. 1982;33(1-3):113-7; & (d)[
Pneuropsychological
disorders after occupational exposure to mercury vapors in El
Bagre
(Antioquia, Colombia)] Rev Neurol.
2000 Oct 16-31;31(8):712-6. Tirado V, Garcia MA et al; &
(e) Chronic
neurobehavioural
effects of
mercury poisoning on a group of Zulu chemical workers. Brain Inj. 2000
Sep;14(9):797-814. Powell TJ: & (f) Neurobehavioral effects
of acute exposure to inorganic mercury vapor. Appl
Neuropsychol
.
1999;6(4):193-200, Haut MW, Morrow LA et al: & (g) Personality
traits in miners with past occupational elemental mercury
exposure. Environ Health
Perspect
. 2006
Feb;114(2):290-6;
Kobal
Grum
D,
Kobal
AB
(122)
B.Ono
et al, “Reduced tyrosine uptake in strains sensitive to inorganic mercury”,
Genet, 1987,11(5):399-
(125) U.S.
CDC, National Center
for Environmental
Health , National Report on Human Exposure to Environmental Chemicals, 2001,
www.cdc.gov/nceh/dls/report/Highlights.htm ; & National Research
Council, Toxicological Effects of Methyl mercury (2000), pp. 304‑332: Risk
Characterization and Public Health Implications,
Nat'l
Academy Press 2000.
& U.S.
Centers for Disease Control, Morbidity and Mortality Weekly Report, Mar 2,
2001,
www.cdc.gov/mmwr/preview/mmwrhtml/mm5008a2.html; & U.S.
CDC,
Second National Report on Human
Exposure to Environmental
Chemicals, www.cdc.gov/exposurereport/
(126) (
a)Singh I,
Pahan
K, Khan M, Singh AK. Cytokine-mediated
induction of ceramide production is redox-sensitive. Implications to
proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J
Biol Chem. 1998 Aug 7;273(32):20354-62; &
Pahan
K, Raymond JR, Singh I. Inhibition of phosphatidylinositol 3-kinase induces
nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial
cells. J. Biol. Chem. 274: 7528-7536, 1999; &Xu J, Yeh CH, et al,
Involvement of de novo ceramide biosynthesis in tumor necrosis
factor-alpha/cycloheximide-induced cerebral endothelial cell
death. J Biol Chem. 1998 Jun 26;273(26):16521-6; &
Dbaibo
GS, El-Assaad W, et
al,
Ceramide
generation by two distinct pathways in tumor necrosis factor alpha-induced cell
death. FEBS Lett. 2001 Aug 10;503(1):7-12; & Liu B,
Hannun
YA.et al, Glutathione regulation of neutral
sphingomyelinase in tumor necrosis factor-alpha-induced cell
death.J
Biol Chem. 1998 May
1;273(18):11313-20; & (b) Noda M,
Wataha
JC, et al, Sublethal, 2-week exposures of dental
material components alter TNF-alpha secretion of THP-1 monocytes. Dent Mater.
2003 Mar;19(2):101-5; & Kim SH, Johnson VJ, Sharma
RP. Mercury inhibits nitric oxide production but
activates proinflammatory cytokine expression in murine macrophage:
differential modulation of NF-
kappaB
and p38 MAPK
signaling pathways. Nitric Oxide. 2002
Aug;7(1):67-74; &
Dastych
J, Metcalfe DD et al,
Murine mast cells exposed to mercuric chloride release granule-associated
N-acetyl-beta-D-hexosaminidase and secrete IL-4 and TNF-alpha. J Allergy
Clin Immunol. 1999 Jun;103(6):1108-14. & (c)
Tortarolo
M,
Veglianese
P, et
al, Persistent
activation
of p38 mitogen-activated protein kinase in a mouse model of familial
amyotrophic lateral sclerosis correlates with disease
progression.. Mol Cell
Neurosci
. 2003
Jun;23(2):180-92.
(128)
M.L.
S.Queiroz
et al, "Immunoglobulin Levels in
Workers Exposed to Inorganic Mercury",
Pharmacol
Toxicol
74:72-75, 1994;
& “Presence of Micronuclei in lymphocytes of mercury exposed workers’,
Immunopharmacol
Immunotoxicol
,
1999, 21(1):141-50; &
D.C.Santos
, “Immunoglobulin
E in mercury exposed workers”, 1997, 19(3):383-92..
(140)
R.
L.Siblerud
, "Health Effects After Dental Amalgam
Removal", J Orthomolecular Med 5(2): 95 -106.
(141)
RL.Siblerud
et al, "Evidence that mercury from
dental fillings may be an etiological factor in smoking",
Toxicol
Lett,v68,n3,1993,p307- & v69(3):305.
(145) Carpenter
DO. Effects of metals on the nervous system of humans and
animals. Int J
Occup
Med Environ Health.
2001;14(3):209-18; &
J.M.Gorell
et al,
“Occupational exposure to mercury, manganese, copper, lead, and the risk of
Parkinson’s disease”, Neurotoxicology, 1999,
20(2-3):239-47; & J.M.
Gorell
et
al,”Occupational
exposures to metals as risk
factors for Parkinson's disease”, Neurology, 1997 Mar, 48:3, 650‑8;
&
Discalzi
G,
Meliga
F
et al; Occupational Mn parkinsonism: magnetic resonance imaging and clinical
patterns following CaNa2-EDTA chelation. Neurotoxicology. 2000
Oct;21(5):863-6.
(147) .
M.Wood
,"Mechanisms
for the Neurotoxicity of
Mercury", in
Organotransitional
Metal Chemistry,
Plenum Publishing Corp, N.Y, N.Y, 1987. & R.P. Sharma et al,
“Metals and Neurotoxic Effects”, J of Comp Pathology, Vol 91, 1981.
(148)
H.
R.Casdorph
, Toxic Metal Syndrome, Avery
Publishing Group, 1995.
(149) (
a)
B.Choi
et al, "Abnormal neuronal migration of human fetal brain", Journal of
Neurophalogy
, Vol 37, p719-733, 1978; & (b)
L.Larkfors
et
al,"Methyl
mercury induced alterations in the nerve growth factor level in the
developing brain ", Res Dev Res,62(2),1991,287- ; & (c)
Belletti
S,
Gatti
R. Time course assessment of methylmercury effects on C6 glioma
cells:
submicromolar
concentrations induce
oxidative DNA damage and apoptosis. J
Neurosci
Res. 2002 Dec 1;70(5):703-
11;
(158) Wenstrup et al, “Trace
element imbalances in the brains of Alzheimer’s patients”, Research, Vol
533,p125-131,1990; &
F.L.Lorscheider,B.Haley,et
al, “Mercury vapor inhibits tubulin binding ”, FASEB
J,9(4):A-3485.,1995 & Vance et al, 1988,
Neurotoxicology, 9:197-208; & de Saint-Georges et al,
“Inhibition by mercuric chloride of the in vitro polymerization of
microtubules”, CR Seances Soc Biol Fil, 1984; 178(5):562-6.
(160) B.
Windham, Cognitive and Behavioral Effects of Toxic Metals,
2003. (over 150 medical study references)
www.flcv.com/tmlbn.html
;
&
B.Windham
,
"Health Effects of Toxic Metals: An Annotated Bibliography",1999;
www.flcv.com/tm98.html; &National Human Adipose Tissue Survey FY82,
EPA-560/5-86-039, Dec.1986; *EPA Report: 100% Of
Human Adipose Fat Samples Studied Are Laced With Chlorinated Solvents and Heavy
Metals www.health‑doc.com/healtharticles/bftoxicityreport.html
(161)
F.
L.Lorscheider
et al, “Inorganic mercury and
the CNS: genetic linkage of mercury and antibiotic
resistance”,Toxicology,1995,97(1): 19-22; &
M.C.Roberts
,
Dept. Of Pathobiology, Univ. Of Washington, “Antibiotic resistance in
oral/respiratory bacteria”, Crit Rev Oral biol Med, 1998;9(4):522-
(166)
H.Basun
et al,
J Neural
Transm
Park
Dis Dement Sect, “Metals in plasma and cerebrospinal fluid in
normal aging and Alzheimer’s disease”,1991,3(4):231-58
(169)
C.
H.Ngim
et al,
Neuroepidemiology,”Epidemiologic
study on the association between body burden mercury level and idiopathic
Parkinson’s disease”, 1989, 8(3):128-41.
(170) Birgitta
Brunes
,
Adima
Bergli
, From
MS
diagnosis to better health
,1996. www.melisa.org; & DAMS,
Recoveries from MS after amalgam
replacement, www.whale.to/d/ms1.html
;
& Maile Pouls, Townsend Letter, 1999,
www.heall.com/healingnews/may/heavy_metals.html
(175) F. Monnet-
Tschudi
et al, “Comparison of the developmental effects of
2 mercury compounds on glial cells and neurons in the rat telencephalon”, Brain
Research, 1996, 741: 52-59; & Chang LW, Hartmann HA, “Quantitative
cytochemical studies of RNA in experimental mercury poisoning”, Acta
Neruopathol
(Berlin), 1973, 23(1):77-83;.&(c) Sorensen
FW, Larsen JO, Eide R,
Schionning
JD
;
Neuron
loss in cerebellar cortex of rats exposed to mercury vapor: a stereological
study.
Acta
Neuropathol
(
Berl
). 2000 Jul;100(1):95-100.
(176)
Niederhofer H. Ginkgo biloba treating patients with attention-deficit
disorder.
Phytother
Res. 2009 May 14.
(184)
T.
H.Ingalls
, Clustering of multiple sclerosis in
Galion, Ohio, 1982-1985. Amer J Forensic
Med
Pathol
1989; 10: 213-5; & “Endemic
clustering of multiple sclerosis in time and place”, Am
J.Fors
Med
Path, 1986,7:3-8; & J
Forsenic
Medicine and Pathology, Vol 4, No 1, 1953; &
Epidemiology, etiology
and prevention of
MS”,Am
J Fors Med &
Pathology, 1983, 4:55-61; &
Craelius
W, Comparative
epidemiology of multiple sclerosis and dental caries”, J of Epidemiological
and Community
Health
32:155-65.
(190)
P.Urban
et al, “Neurological examination on 3 groups
of workers exposed to mercury vapor”,
Eur
J
Neurology, 1999, 6(5): 571-7; & B.
Polakowska
,
“Neurological Assessment of Health Status in Dentists”, Med
Pr
,
1994, 45(3):221-5; &
L.Ekenvall
et al, “Sensory
perception in the hands of dentists” J Work Environ Health, 1990, 16(5):334-9.
(199)
Kraub
P,
Deyhle
M, Maier KH, Roller HD, "Field Study
on the mercury content of saliva", Heavy Metal Bull, vol.3, issue 1, April
'96; & Dr.
P.Kraub
&
M.Deyhle
,
Universitat
Tubingen-
Institut
fur
Organische
Chemie
, “Field Study on the Mercury Content of
Saliva”, 1997 (20,000 people tested for mercury level in saliva and
health status/symptoms compiled);
http://www.xs4all.nl/~stgvisie/AMALGAM/EN/SCIENCE/tubingen.html
www.bio.net/bionet/mm/toxicol/1999-September/002567.html
(204) Tom
Warren, Beating Alzheimer’s, Avery Publishing Group, 1991.
www.the7thfire.com/ADApolitics.htm
& www.whale.to/m/alzheimer.html
(207) Pendergrass JC, Haley
BE, Univ. Of Kentucky Dept. Of Chemistry
“ The
Toxic Effects of Mercury on CNS
Proteins: Similarity to Observations in Alzheimer’s Disease”,
IAOMT Symposium paper, March 1997 & “Mercury Vapor Inhalation
Inhibits Binding of GTP ...-Similarity to Lesions in Alzheimer’s Diseased
Brains”, Neurotoxicology 1997,
18(2)::315-24; & Met Ions Biol Syst, 1997,
34:461-
(210) Mats Berlin, “Is
amalgam in dental fillings hazardous to health?
”,
Lakartidningen
, 1992; 89(37):2918-23;
& “Mercury in dental filling materials- environmental
medicine risk analysis”, in: [Swedish Council for Coordinating and
Planning Research, Amalgam and Health, FRN,1999];
& Berlin, M;
et al. Prenatal Exposure to Mercury Vapor: Effects on Brain Development. The
Toxicologist, 12(1):7(A245), 1992; & "Expert Consulted For Amalgam
Study Demands Amalgam Ban", Swedish Dental Materials
Study ,
"
Dagens
Nyheter
", April 26 2003,
www.tv4.se/nyheterna/lopsedel.html
www.dn.se/DNet/jsp/polopoly.jsp?d=597&a=134259&previousRenderType=6
(211)
M.
J.Vimy
and F.L.
Lorscheider
,
Faculty of Medicine, Univ. Of Calgary, July 1991. (Study
findings) & J. Trace Elem.
Exper
. Med.,
1990,3, 111-123.
(
212)(
a) Ziff, M.F., “Documented
clinical side effects to dental amalgams”, ADV. Dent. Res.,
1992;
1(6):131-134; &
Ziff,
S.,
Dentistry
without Mercury
, 8th
Edition, 1996, Bio-Probe, Inc. , ISBN 0-941011-04-6; &
Dental
Mercury
Detox
,
Bio-Probe,
Inc. http://www.bioprobe.com. (Cases:
FDA Patient Adverse Reaction Reports-762,
Dr.
M.Hanson
-Swedish patients-519, Dr. H. Lichtenberg-100
Danish patients ,
Siblerud
, RL.
Health effects after dental amalgam removal. J.
Orthomol
. Med.
5, 1990, 95-106(86 patients); & P. Larose. The effect of amalgam
removal on 37 health symptoms in humans. Updated 1992 from study reported
in Dental Health & Facts 2(1) 1989. Foundation for Toxic-free
Dentistry/Bio-Probe,
Orlando(
80 patients); &
Zamm
, AV. Removal of dental mercury: often an effective
treatment for the very sensitive patient.
J
Orthomol
. Med. 5, 1990,
138-142
(22
patients)
www.flcv.com/hgrecovp.html
&
(b)
Hovmand
, O. Oral
galvanisme
-
erfaringer
fra
praxis.
Tandlaegebladet
91,
1987, 473-476. & (c)over 1000 additional cases of significant improvement
reported directly to FDA)
(213) Dr. C.
Kousmine
, Multiple Sclerosis is Curable, 1995.
(219) D.E.
Cutright
et al, Dept. Of
Prosthodontics, Temple
Univ.“
Systemic
mercury levels caused by inhaling mist during high-speed amalgam grinding”, J
Oral Med 28(4):100-104,1973 ; & (b)
A.Nimmo
et al, “Inhalation during removal of amalgam restorations”,
J
Prosthet
Dent, 63(2):1990
Feb, 228-33; &(c) Stonehouse CA, Newman
AP. Mercury
vapour
release from
a dental aspirator. Br Dent J 2001 May
26;190(10):558-60 &(d
)
Taskinen
H,
Kinnunen
E,
Riihimaki
V. A possible case of mercury-related
toxicity resulting from the grinding of old amalgam restorations.
Scand
J Work Environ Health 1989; 15 (4): 302-4;
&
http://atsdr1.atsdr.cdc.gov:8080/97list.html.
(222) M.
Daunderer
,
Handbuch
der
Amalgamvergiftung
,
Ecomed
Verlag, Landsberg 1998, ISBN 3‑609‑71750‑5 (in
German); & “Improvement of Nerve and Immunological Damages after Amalgam
Removal”, Amer. J. Of Probiotic Dentistry and Medicine, Jan
1991;
&
Toxicologische
erfahrungen
am
menchen
;
Quecksilber
in der
umwelf
-hearing
zum
amalgamproblem
”,
Niedersachsiscles
Umweltministerium
,
1991; & “Amalgam”,
Ecomed
-Verlag, Landsberg,
1995; & “
Amalgamtest
”, Forum
Prakt.Allgen.Arzt
,
1990, 29(8): 213-4; & “
Besserung
von
Nerven
- und
Immunschaden
nach
Amalgamsanierung
”,
Dtsch.Aschr
. F.
Biologische
Zahnmedzin
, 1990, 6(4):152-7.
(
amalgam
removal & DMPS, over 5,000 cases)
(226) (a)B.J.
Shenker
et al, Dept. Of Pathology, Univ. Of Penn. School of Dental Med.
,”
Immunotoxic
effects of mercuric
compounds on human lymphocytes and monocytes: Alterations in cell
viability”
Immunopharmacologicol
Immunotoxical
, 1992, 14(3):555-77; &
M.A.Miller
et al, “Mercuric chloride induces apoptosis in
human T lymphocytes”,
Toxicol
Appl
Pharmacol
, 153(2):250‑7 1998;& Rossi
AD,Viviani
B,
Vahter
M. Inorganic mercury modifies Ca2+ signals, triggers
apoptosis, and potentiates NMDA toxicity in cerebral granule
neurons. Cell Death and Differentiation
1997; 4
(4):317-24.
& Goering PL, Thomas D,
Rojko
JL, Lucas
AD. Mercuric chloride-induced apoptosis is dependent on protein
synthesis.
Toxicol
Lett 1999; 105(3): 183-
95; ,
&(b) B.J.
Shenker
et al “Immune suppression of human T-cell
activation”,
Immunopharmacologicol
Immunotoxical
, 1992, 14(3):555-77, & 14(3):539-53;
& 1993, 15(2-3):273-90;
(228) (a)
A.
F.Zamm
, “Removal of dental mercury: often an
effective treatment for very sensitive patients”, J
Orthomolecular Med, 1990, 5(53):138-142. (22 patients); &
(b)Dr. T. Rau, Paracelsus
Alergy
Clinic,
Lustmuhle
, Switzerland
,
Allergies: Causes, Clarification, Treatment; Explore, 8(4),1996,
www.explorepub.com/articles/bio‑therapy.html ; & (c) Dr. B.
Shelton, Director, The Allergy Center, Phoenix, Arizona,
www.hamptonroadspub.com/main/books/excerpts/elements2.html; &
(d) E. Cutler,
Winning the War against Asthma &
Allergies
, Delmar Learning; 1st edition (July 9, 1997)
(229)
M.Davis
, editor,
Defense
Against
Mystery
Syndromes”
,
Chek
Printing Co., &
March, 1994(case histories documented);
& Andrew
Hall Cutler, PhD, PE;
Amalgam
Illness:
Diagnosis
and Treatment
;
1996 , www.noamalgam.com/
.(
233)
F.Berglund,Bjerner
/
Helm,Klock,Ripa,Lindforss,Mornstad,Ostlin
), “Improved
Health after Removal of
dental amalgam fillings”, Swedish Assoc. Of
Dental
Mercury Patients
, 1998.
(www.tf.nu
) ,
(a)
Lindforss
,
H,
Marqvardsen
, O, Olsson, S, Henningsson, M.
Effekter
på
hälsan
efter
avlägsnandet
av
amalgamfyllningar
(Effects on health after removal of
amalgam fillings).
Tandläkartidn
. 86(4),
1994, 205-211; (503 patients);
& (
b)
Östlin
, L.
Amalgamutbyte
-
en
väg
mot
bättre
hälsa
?
(Amalgam
removal - a road to better health?)
Försäkringskassan
,
Stockholms
län
, 1991(308 patients); &
(c)Olsson, G & Lindh, U.
Veränderung
des
allgemeinen
Gesundheitszustand
nach
Amalgamentfernung
.
(Changes in general health after amalgam removal) GZM,
Ganzheitl
.
Zahnmed
. 2(1),
1997, 22-28(253 patients); &
(d)
Strömberg
, R,
Langworth
, S.
Förbättras
hälsan
efter
borttagning
av amalgam?
(Does health improve after removal
of amalgam?)
Tandläkartidn
. 90(9), 1998,
23-29(233 patients); & (e)LEK-
studien
,
Landstinget
Dalarna,
Bjerner
, B
&
Hjelm
, H. dec. 1991, LEK-
studien
Dalarna.
Sammanställning
inför
hearing med
SoS:s
"tungmetallgrupp
",
90-11-21(207 patients); &(f)
Klock
, B,
Blomgren
, J,
Ripa
, U,
Andrup
B.
Effekt
av
amalgamavlägsnande
på
patienter
som
misstänker
att
de
lider
eller
har
lidit
av
amalgamförgiftning
. (Effect of amalgam removal in
patients who suspect amalgam poisoning)
Tandläkartidningen
81, 1989, 1297-1302(198 patients); & (g)Sven
Langworth
et al, Amalgam news and
Amalgamkadefonden
,
1997.(
www.tf.nu)
(234) (a) Cooper
GS,Dooley
MA., et al, NIEHS,
Occupational risk factors for the
development of systemic lupus erythematosus, J
Rheumatol
.
2004 Oct;31(10):1928-33; & (
b)
P.E.
Bigazzi
, “Autoimmunity and Heavy Metals”, Lupus,
1994; 3: 449-453; & (c)Pollard KM, Pearson Dl,
Hultman
P. Lupus-prone mice as model to study xenobiotic-induced
autoimmunity. Environ Health
Perspect
1999; 107(Suppl 5): 729-735; & Nielsen JB;
Hultman
P. Experimental studies on genetically determined susceptibility to
mercury‑induced autoimmune response. Ren Fail 1999 May‑Jul;21(3‑4):343‑8;
&
Hultman
P,
Enestrom
S, Mercury induced antinuclear antibodies in
mice, Clinical
and
Exper
Immunology, 1988, 71(2): 269-274; &
(d)Robbins SM, Quintrell NA, Bishop JM. Mercuric chloride activates
the
Src
-family protein tyrosine kinase,
Hck
in myelomonocytic cells.
Eur
J
Biochem
. 2000 Dec;267(24):7201-8; & (e) Via CS,
Nguyen P,
Silbergeld
EK, et al, Low-dose exposure to
inorganic mercury accelerates disease and mortality in acquired murine lupus,
Environ Health
Perspect
. 2003, 111(10):1273-7; &
(f)
Silbergeld
EK, Silva IA, Nyland JF. Mercury and autoimmunity:
implications for occupational and environmental health.
Toxicol
Appl
Pharmacol
. 2005 Sep
1;207(2 Suppl):282-92
. .
(241)
R.Schoeny
, U.S.EPA, “Use of genetic toxicology data
in U.S. EPA risk assessment: the mercury study”, Environ Health
Perspect
, 1996, 104, Supp 3: 663-73; &
C.H.Lee
et al, “Genotoxicity of
phenylHg
acetate in humans as compared to other mercury compounds”,
392(3):269-76.
(246)
K.Iyer
et al, “Mercury Poisoning in a dentist”, Arch
Neurol,1976, 33:788-790.
(248)
Y.Finkelstein
,“The
enigma of parkinsonism in chronic
borderline mercury intoxication, resolved by challenge with
penicillamine. Neurotoxicology, 1996, Spring, 17(1): 291-5: &
Hryhorczuk
E et al, Treatment of Mercury Intoxication in a
Dentist with
penicilamine
, J
Toxicol
Clin
Toxicol
, 1982, 19(4):401-
(249)
C.
H.Ngim
et al, Dept. of Occupational Medicine,
Univ. Of
Singapore,“
Chronic
neurobehavioral effects of elemental mercury
in dentists”, British Journal of Industrial Medicine,
1992; 49(11):782-790.
(250)
B.
A.Rybicki
et
al,”Parkinson's
disease mortality and the industrial use of heavy metals in Michigan”, Mov
Disord
, 1993, 8:1, 87‑92. &
Yamanaga
H, “Quantitative analysis of tremor in Minamata
disease”,
Tokhoku
J Exp Med, 1983 Sep, 141:1, 13‑22,
&
Studies documenting mercury causes
ataxia/tremor
www.myflcv.com/ataxiaHG.html
(251) (a)
Y.Omura
et al, Heart Disease Research Foundation,
NY,NY, “Role of mercury in resistant infections and recovery after
Hg detox with cilantro”, Acupuncture & Electro-Therapeutics Research,
20(3):195-229, 1995; &(b) “Mercury exposure from silver
fillings”, Acupuncture & Electrotherapy Res, 1996, 133- ; &
(c)
Omura
, Yoshiaki; Abnormal
Deposits of Al, Pb, and Hg in the Brain,
Particularly in
the Hippocampus, as One of the Main Causes of Decreased Cerebral Acetylcholine,
Electromagnetic Field Hypersensitivity, Pre-Alzheimer's Disease, and
Autism in Children; Acupuncture & Electro-Therapeutics Research, 2000, Vol.
25 Issue 3/4, p230, 3p
(254) al-Saleh I,
Shinwari
N. Urinary mercury levels in females: influence of dental amalgam
fillings.
Biometals
1997; 10(4): 315-23;
& (b) Mortada WL,
Sobh
MA, El-
Defrawy
MM, Farahat SE. Mercury in dental restoration: is there a risk of
nephrotoxicity? J Nephrol. 2002 Mar-Apr;15(2):171-6; &
(c)
Zabinski
Z;
Dabrowski
Z;
Moszczynski
P;
Rutowski
J. The activity of erythrocyte enzymes and basic indices of
peripheral
blood erythrocytes
from
workers chronically exposed to
mercury vapors.
Toxicol
Ind Health 2000 Feb;16(2):58‑64.
(255) D.C. Rice, “Evidence
of delayed neurotoxicity produced by methyl mercury developmental exposure”,
Neurotoxicology, Fall 1996, 17(3-4), p583-96; &(b) Weiss B, Clarkson
TW, Simon W. Silent latency periods in methylmercury poisoning
and in neurodegenerative disease. Environ Health
Perspect
.
2002 Oct;110 Suppl 5:851-4: &©
Residual neurologic
deficits 30 years after occupational exposure to elemental
mercury. Neurotoxicology. 2000 Aug;21(4):459-74.,
Letz
R,
Gerr
F,
Cragle
D, Green RC, Watkins J, Fidler AT.
(257) I. Smith et al,
“Pteridines and mono-amines: relevance to neurological
damage”, Postgrad Med J, 62(724): 113-123, 1986; &
A.D.Kay
et al, “Cerebrospinal fluid
biopterin is decreased in Alzheimer’s disease”, Arch Neurol,
43(10): 996-9, Oct 1986; &
T.Yamiguchi
et al, “Effects of tyrosine administration on
serum
bipterin
In patients with
Parkinson’s Disease and normal controls”, Science, 219(4580):75-77,
Jan 1983; &
T.Nagatsu
et al, “
Catecholoamine
-related
enzymes and the biopterin cofactor in Parkinson’s”, Neurol, 1984, 40: 467-73.
(258) Mercury Induced Alzheimer’s
Disease: Accelerating
Incicdence
?,
Bull Environ
Contam
Toxicol
,
2001, 67: 800-6. Ely,
J.T.A.
(262) Chang LW, “The
Neurotoxicology and pathology of organomercury,
organolead
,
and organotin” J
Toxicol
Sci, 1990, 15 Suppl 4: 125-
51; &
“Latent effects of methyl mercury
on the nervous system after prenatal exposure”, Environ Res 1977, 13(2):
171-85.
(264) B.R. Danielsson et al, “”
Behavioral effects of prenatal metallic mercury inhalation exposure in
rats”,
Neurotoxicol
Teratol
, 1993,
15(6): 391-
6;&
A. Fredriksson et
al,”Prenatal
exposure to metallic mercury
vapor and methyl mercury
produce interactive
behavioral changes in adult rats”,
Neurotoxicol
Teratol
,
1996,
18(2): 129-34; & “Behavioral effects of neonatal
metallic mercury
exposure in rats”,
Toxicology,
1992,
74(2-3):151‑160;
(271)
B.
A.Weber
, “The Marburg Amalgam Study”,
Arzt
und Umwelt, Apr, 1995; (266
cases) & (b) “Amalgam and Allergy”, Institute
for Naturopathic Medicine,
1994; www.karlloren.com/ultrasound/p23.htm
& ©
“Conjunctivitis
sicca(
dry eye study)”,Institute
for Naturopathic Medicine, 1994; &
, “Alternative
treatment
of
Multiple
Schlerosis
, Tumor,
or
Cancer”, Institute
for
Naturopathic
Medicine 1997 (40 MS
cases
),
(273)
R.Schiele
et
al, Institute of Occupational Medicine, Univ. Of
Erlamgem
- Nurnberg, “Studies of organ mercury content
related to number of
amalgam
fillings
”,Symposium
paper, March 12, 1984, Cologne, Germany; (& 38); & “
Quecksilber-Mobiliztion
durch
DMPS
bei
Personen
mit
und
ohne
Amalgamfullungen
”,
Zahnarztl
. Mitt, 1989, 79(17): 1866-1868; &
J.
J.Kleber
, “
Quecksilberverkonzen
-
tration
im
Urin
nach
DMPS” in [Status Quo and Perspectives of
Amalgam], L.T. Friberg(ed.), Georg-
Thieme
Verlag, Stuttgart, New York, 1005, p 61-69.
(274)
L.Friberg
et al, “Mercury in the brain
and CNS in relation to amalgam fillings”,
Lakartidningen
,
83(7):519-521,1986(Swedish Medical Journal); &
T.Suzuki
et al, Ind Health,4:69-75,1966.
(275)
L.
M.Mikhailova
et al, “Influence of occupational
factors on disease of reproductive organs”,
Pediatriya
Akusherstvoi
Ginekologiya,33(6):56-58,1971;
&
Elghany
NA, Stopford W, Bunn WB,
Fleming LE. Occupational exposure to inorganic mercury
vapour
and reproductive outcomes.
Occup
Med (Lond). 1997 Aug;47(6):333-6.
(276) ATSDR/EPA Priority List for 2005: Top 20
Hazardous Substances, Agency for Toxic Substances and
Disease Registry, U.S. Department of Health
and Human Services, www.atsdr.cdc.gov/clist.html & (b)
U.S.
Environmental
Protection Agency, Hazardous Air Pollutant Hazard
Summary,
Fact
Sheets, EPA: In Risk
Information
System, 1998, www.epa.gov/mercury/information.htm#fact_sheets &
&(c)
U.S. EPA, Region I, 2001,
www.epa.gov/region01/children/outdoors.html
282) Press Release,
Swedish Council for Planning and Coordinating Research (FRN), Stockholm, 19
February, 1998; & The Swedish Dental Material
Commission _
_ Care and Consideration
Kv
.
Spektern
,
SE _103 33 Stockholm, Sweden or on the web site,
2003 www.dentalmaterial.gov.se/Mercury.pdf
(285)
R.C.Perlingeiro
et al, “Polymorphonuclear
phagentosis
in workers
exposed to mercury vapor”, Int J
Immounopharmacology
”,
16(12):1011-7,1994; & Hum Exp
Toxicol
1995,
14(3):281-6; & M.L. Queiroz et al,
Pharmacol
Toxicol
, 1994, 74(2):72-5; & (b)
J.W.Albers
et al, “Neurological abnormalities associated
with remote occupational elemental mercury
exposure”,Ann
Neurol 1988, 24(5):651-9 ; & ©
L.Soleo
et al, “Effects of low exposure to inorganic mercury on psychological
performance”, Br J Ind Med, 1990, 47(2):105-9; & (d)
P.J.Smith
et
al, “Effect of exposure to elemental mercury on short term memory”, Br J Ind
Med 1983, 40(4):413-9.; & (e)
M.S.Hua
et al,
“Chronic elemental mercury intoxication”, Brain
Inj
,
1996, 10(5):377-84; & (f) Gunther W, et al, Repeated neurobehavioral
investigations in workers ..., Neurotoxicology 1996; 17(3-4):605-14; & (g)
Levine SP; Cavender GD;
Langolf
GD;
Albers JW. Elemental mercury exposure: peripheral
neurotoxicity. Br J Ind Med 1982 May;39(2):136‑9.
(286) M. Lai et al,
“Sensitivity of MS detections by MRI”, Journal of Neurology, Neurosurgery,
and Psychiatry, 1996, 60(3):339-341.
(287) M.C. Newland et
al
,”Behavioral
consequences of in
utero exposure to mercury vapor in squirrel monkeys”, Toxicology & Applied
Pharmacology, 1996, 139: 374-386; & “Prolonged behavioral effects of in
utero exposure to methyl mercury or lead”,
Toxicol
Appl
Pharmacol
, 1994, 126(1):6-15;
&
K
.Warfvinge
et al, “Mercury
distribution in neonatal cortical areas ...after exposure to mercury vapor”,
Environmental Research, 1994, 67:196-208.
(288) (a)
Hisatome
I,
Kurata
Y, et al;
Block of sodium channels by divalent mercury: role of specific cysteinyl
residues in the P-loop region.
Biophys
J.
2000 Sep;79(3):1336-45;
& Bhattacharya
S, Sen S et al, Specific binding of inorganic mercury to Na(+)-K(+)-ATPase in
rat liver plasma membrane and signal transduction.
Biometals
. 1997 Jul;10(3):157-62; &
Anner
BM,
Moosmayer
M,
Imesch
E. Mercury blocks Na-K-ATPase by a
ligand-dependent and reversible mechanism. Am J Physiol. 1992
May;262(5 Pt 2
):F
830-6. &
Anner
BM,
Moosmayer
M. Mercury inhibits Na-K-ATPase primarily at the cytoplasmic
side. Am J
Physiol
1992; 262(5 Pt2
):F
84308; & Wagner CA,
Waldegger
S,et
al; Heavy metals inhibit Pi-induced
currents through human brush-border NaPi-3 cotransporter in Xenopus oocytes..
Am J Physiol. 1996 Oct;271(4 Pt 2
):F
926-30; & Lewis
RN; Bowler K. Rat brain (Na+‑K
+)ATPase
:
modulation of its ouabain‑sensitive K+‑
PNPPase
activity by thimerosal. Int J
Biochem
1983;15(1):5‑7
&
(b)
Rajanna
B, Hobson M, Harris L, Ware L,
Chetty CS. Effects of cadmium and mercury on Na(+)-
K(
+) ATPase and uptake of 3H-dopamine in rat brain
synaptosomes. Arch Int
Physiol
Biochem
1990, 98(5):291-6; &
M.Hobson
,
B.Rajanna
,
“Influence of mercury on uptake of dopamine and norepinephrine”,
Toxicol
Letters, Dep 1985, 27:2-3:7-14;
& & McKay SJ, Reynolds JN,
Racz
WJ. Effects of mercury compounds on
the spontaneous and potassium-evoked release of [3
H]dopamine
from
mouse
striatial
slices. Can J
Physiol
Pharmacol
1986,
64(12):1507-14;
&
Scheuhammer
AM;
Cherian MG. Effects of heavy metal cations, sulfhydryl
reagents and other chemical agents on striatal D2 dopamine
receptors.
Biochem
Pharmacol
1985 Oct 1;34(19):3405‑
13 ;
&
K.R.Hoyt
et al, “Mechanisms of dopamine-induced cell death and differences from
glutamate Induced cell death”, Exp Neurol 1997, 143(2):269-81;
& & (c)
Offen
D, et al, Antibodies
from ALS patients inhibit dopamine release mediated by L-type calcium
channels. Neurology 1998 Oct;51(4):1100-3.
(290) D.
Echeverria et al, “Neurobehavioral effects from exposure to
dental amalgam
:
new distinctions between recent exposure and Hg body
burden” FASEB J, Aug 1998, 12(11):971-980;
& (b) Echeverria, Woods JS,
Heyer
NJ,
Rohlman
DS,
Farin
FM, Bittner AC Jr, Li T,
Garabedian
C. Chronic low-level mercury
exposure, BDNF polymorphism, and associations with cognitive and motor
function.
Neurotoxicol
Teratol
.
2005 Nov-Dec;27(6):781-
96; &
The
association between a genetic polymorphism of coproporphyrinogen oxidase,
dental mercury exposure and neurobehavioral response in humans.
Neurotoxicol
Teratol
. 2006
Jan-Feb;28(1):39-48.
Epub
2005 Dec
15; Echeverria D, Woods JS, et al.
& (
c)Amalgam and
Health, Swedish Council for Planning and Coordination of Research, 1999;
p297-307
(291)
H.
A.Huggins
& TE Levy,
“Cerebrospinal fluid protein changes in MS after Dental amalgam removal”,
Alternative Med Rev, Aug 1998, 3(4):295-300.
(294)
Siblerud
,
Robert L., et al. Psychometric evidence that dental amalgam mercury may be an
etiological factor in manic depression. Journal of
Orthomolecular Medicine, Vol. 13, No. 1, First Quarter 1998, pp. 31‑ 40
www.yourhealthbase.com/amalgams.html
&
Bioplar
Disorder: A possible dental connection, Dr. G. H.
Smith, International Center for Nutritional Research,
http://www.icnr.com/articles/bipolardentalconnection.html
; &
Lieb
J, Hershman D. Isaac Newton
:
mercury poisoning
or manic depression?. Lancet. 1983 Dec
24-31;2(8365-66):1479-80.
(295) Cecil
Textbook of Medicine, 20th Ed., Bennett & Plum, W.B. Saunders and Company,
Philadelphia, 1996, p
69; &
Comprehensive
Psychiatry, 18(6), 1977, pp595-598, &
Poisoning & Toxicology
Compendium,
Leikin
and
Palouchek
, Lexi-Comp.,
Cleveland, 1998; & Harrison’s Principles Of Internal Medicine, 14th Ed.,
McGraw-Hill,
N.y.
, 1998;
&
Sunderman
FW. Perils of
mercury. Ann Clin Lab Sci 1988 Mar‑Apr;18(2):89‑101.
(296)
L.Bucio
et al, Uptake, cellular
distribution and DNA damage produced by mercuric chloride in a human
fetal hepatic cell line.
Mutat
Res 1999
Jan 5;423(1‑2):65‑72;
& (
b) Ho PI,
Ortiz D, Rogers E, Shea TB. Multiple aspects of homocysteine
neurotoxicity: glutamate excitotoxicity, kinase hyperactivation
and DNA damage. J
Neurosci
Res. 2002 Dec 1;70(5):694-702; &(c) Snyder RD;
Lachmann
PJ; Thiol involvement in the inhibition of DNA repair by
metals in mammalian cells. Source
Mol
Toxicol
, 1989 Apr‑Jun, 2:2, 117‑
28 ;
& (d)
L.Verschaeve
et al, “Comparative in vitro cytogenetic studies in mercury-exposed human
lymphocytes”,
Muta
Res, 1985,
157(2-3):221-6; & (e) L.
Verschaeve
,“Genetic
damage induced by low level mercury exposure”,
Envir
Res,12:306-10,1976.
(297) (a) Mercury (II) alters
mitochondrial activity of monocytes at sublethal doses via oxidative stress
mechanisms. Messer RL, Lockwood PE, J Biomed Mater Res B Appl
Biomater
. 2005 Nov;75(2):257-63; & Effect of
Methyl Mercury on Phosphorylation, Transport, and Oxidation in Mammalian
Mitochondria,
Nobuhito
SONE, Margareta K.
LARSSTUVOLD
*
and Yasuo
KAGAWA,
The
Journal of Biochemistry
Volume82, Issue3
, Pp.
859-868; & mercury-mitochondria citations,
www.mitochondrial.net/showcitationlist.php?keyword=mercury
; &
(b) Mitochondrial DNA mutations as an important contributor to aging and
degenerative …diseases,
Linnane
AW et al, Lancet, Mar 1989, 1(8639),
p642-5;& Mitochondrial dynamics …in cell death and neurodegeneration, Cho
DH, et al, Cell Mol Life Sci, June 2010; & …Mitochondrial theory of aging:
roles of
mtDNA
mutation and oxidative stress in human
…aging,
Zhonghua
Yi Xue Za Zhi (
Taipai
),
2001, 64(5):259-70;&
Mitochondrial
function,
fibre
types, and aging, Conley KE et
al, Exp
Physiol
, 2007, 92(2):333-9.
(298)
Mitochondria in the diabetic heart, Bugger H et al,
Cardiovascular Research, July 2010; & (b)Mitochondrial dysfunction in
cardiac
desease
: ischemia-
reperfusin
,
aging, and heart failure,
Lesnefsky
EJ, et al, J Mol
Cell
Cardiol
, 2001, 33(6):1065-69;
& (c) Mitochondrial dysfunction and Alzheimer’s Disease,
Maruszak
A et al, Prog
Neurophyschopharacol
Biol
Pyschiatry
, Jul 2010; & (d)PPQ prevents
oxidative stress- induced neuronal death through changes in oxidative status of
DJ-1,
Nunome
K et al, Biol Pharm Bull, 2008, 31(7):
1321-6. (Parkinson’s); & (e)Mitochondria damage checkpoint, aging, and
cancer, Singh KK, Ann NY
Acad
Sci, 2006, 1067:
182-90
(299)
Mitochondria: rejuvenate your cells with Pyrroloquinoline Quinone (PPQ), Life
Extension, Special Winter Edition, 2010,
www.lef.org
. (many peer-review studies
cited)
(300)
C.Hock
et al, “Increased blood mercury levels in
patients with Alzheimer’s disease”, J. Neural
Transm
,
1998, 105(1):59-68.
(301) Chang
LW, Neurotoxic
effects of mercury, Environ.
Res.,1977, 14(3):329-73;
& Histochemical
study on the localization and distribution of mercury in the nervous system
after mercury intoxication, Exp Neurol, 1972, 35(1):122-37; &
Ultrastructural studies of the nervous system after mercury
intoxication, Acta
Neuropathol
(Berlin),
1972, 20(2):122-38 and 20(4):316-34.
(302) D,
Klinghardt
, IAOMT Conference & tape, 1998; “large
study by
M.Daunderer
(Germany)
of MS patients after amalgam removal”.
(
303)
H
.V.Aposhian
, Mobilization
of mercury and arsenic in humans by sodium 2,3-dimercapto-1-propane sulfonate
(DMPS).Environ Health
Perspect
. 1998
Aug;106 Suppl 4:1017-25
. ;
& Toxicology,
1995, 97(1-3): 23-38; & “Urinary Mercury
after
Administrationof
DMPS”, FASEB J., 6: 2472-2476, 1992.
(305)
Soderstrom
S, Fredriksson A,
Dencker
L,
Ebendal
T, “The effect of mercury vapor on
cholinergic neurons in the fetal brain, Brain Research & Developmental
Brain Res, 1995, 85:96-108; &
Toxicol
Lett 1995;
75(1-3):133-44.; & E.M. Abdulla et al, “Comparison of neurite outgrowth
with neurofilament protein levels
In neuroblastoma
cells following mercuric oxide exposure”, Clin Exp Pharmocol
Physiol
, 1995, 22(5): 362-3;
& Leong CC, Syed NI,
Lorscheider
FL. Retrograde degeneration of
neurite membrane structural integrity of nerve growth cones following in vitro
exposure to mercury.
Neuroreport
2001 Mar
26;12(4):733-7
(313)
V.D.
M.Stejskal
et al,
“Mercury-specific Lymphocytes: an
indication of mercury allergy in man”, J.
Of Clinical Immunology, 1996, Vol 16(1);31-40.
(317)
S.Zinecker
, “Amalgam:
Quecksilberdamfe
bis ins
Gehirn
”,
der
Kassenarzt
, 1992,
32(4):23; “
Praxiproblem
Amalgam”, Der
Allgermeinarzt
, 1995,17(11):1215-1221.
(1800 patients)
(320)
U.
F.Malt
et al, “Physical and
mental problems attributed to dental amalgam fillings”, Psychosomatic medicine,
1997, 59:32-41.
(322)
P.Engel
, “
Beobachtungen
uber die gesundheit
vor
und
nach
amalgamentfernug
”,
Separatdruck
aus
Schweiz.
Monatsschr
Zahnm
. 1998, vol 108(8
).(
75 cases
amalgam removal) http://soho.globalpoint.ch/paul‑engel (89% significant
improvement) www.melisa.org/articles/engel‑e.pdf
(324) D.
Bangsi
,
Ghadirian
P et
al, “Dental amalgam and multiple sclerosis”,
International J of Epidemiology, 1998, Aug, 27(4):667-71;
& E.
Mauch
et al, “
umweltgifte
und
multiple
sklerose
”, Der
Allgremeinarzt
,
1996, 20:2226-2220; & (c)
McGrother
CW,
Dugmore
C, Phillips MJ, et al: Multiple sclerosis, dental
caries and fillings: a case-control study. Br Dent J, 1999 Sep 11;187(5):
261-4.
(326)
E.Baasch
, “Is multiple sclerosis a mercury allergy?”,
Schweiz arch Neurol
Neurochir
Psichiatr
, 1966, 98:1-19; & J. Clausen, “Mercury and
MS”, Acta Neurol
Scand
, 1993;87:461-; & "Sur
un
cas
de
mercurialisme
chronique
simulant la
sclerose
en
plaque",Nord
med Ark
Stockholm 1880 xii no 17 1‑48 1 pl & P. Le
Quesne,“Metal
-induced
diseases of the nervous system”,1982,Br J Hosp Med,28:534-
(327) (a)G.
Danscher
et al, Environ Res, “Localization of mercury in
the CNS”, 1986, 41:29-43; &(b)
Danscher
G;
Horsted‑Bindslev
P;
Rungby
J. Traces of mercury in organs from primates
with amalgam
fillings. Exp
Mol
Pathol
1990;52(3):291‑9; & (c)
”Ultrastructural localization of mercury after exposure
to mercury vapor”, Prog
Histochem
Cytochem
, 1991, 23:249-255; &(d)
Pamphlett
R,Coote
P , “Entry of low doses of mercury vapor into
the nervous system”, Neurotoxicology, 1998, 19(1):39-47; & (e)
Pamphlett
et al, “Oxidative damage to nucleic acids in
motor neurons containing Hg”, J Neurol Sci,1998,159(2):121-6. (rats &
primates); &
(
f)
Pamphlett
R,
Waley
P, "Motor
Neuron Uptake of Low Dose Inorganic Mercury", J.
Neurological Sciences 135: 63‑67 (1996); &(g)
Schionning
JD,
Danscher
G, "
Autometallographic
inorganic mercury correlates
with degenerative changes in dorsal root ganglia of rats intoxicated
with organic mercury", APMIS 1999 Mar;107(3):303‑10
(
329)(
a)
Arvidson
B; Arvidsson J; Johansson K, "Mercury
Deposits in Neurons of the Trigeminal Ganglia After Insertion of Dental Amalgam
in Rats",
Biometals
; 7 (3) p261-263 1994; &
(b)
Arvidson
B. Inorganic mercury is transported from
muscular nerve
terminasl
to spinal and brainstem
motorneurons
. Muscle Nerve 1992, 15:1089-94;
& B.
Arvidson
et al, Acta Neurol
Scand
, “
Retograde
axonal
transport
of mercury
in primary sensory
neurons” 1990,82:324-237 &
Neurosci
Letters,
1990, 115:29-32; &
Arvidson
B, Arvidsson J. Retrograde
axonal transport of mercury in primary sensory neurons innervating the tooth
pulp in the rat.
Neurosci
Lett. 1990 Jul
17;115(1):29-32. & (c) S.M.
Candura
et al,
“Effects of
mercuryic
chloride and
methyly
mercury on cholinergic
neuromusular
transmission”,
Pharmacol
Toxicol
1997; 80(5): 218-24; &
Castoldi
AF et al,
“Interaction of mercury compounds with muscarinic receptor subtypes in the rat
brain”, Neurotoxicology 1996; 17(3-4):
735-41;
(333)
A.J.Freitas
et al, “Effects of Hg2+ and CH3Hg+ on Ca2+ fluxes in the rat
brain”, Brain Research, 1996,
738(2): 257-64; &
P.R.Yallapragoda
et
al,“Inhibition
of calcium transport by Hg salts” in rat
cerebellum and cerebral cortex”, J Appl
toxicol
,
1996, 164(4):
325-30; &
E.Chavez
et al, “Mitochondrial calcium release by
Hg+2",J Biol Chem, 1988, 263:8, 3582-; & A.
Szucs
et al, Effects of inorganic mercury and methylmercury on the ionic currents of
cultured rat hippocampal neurons. Cell Mol
Neurobiol
,
1997,17(3): 273-8; &
D.Busselberg
,
1995, “Calcium channels as target sites of heavy metals”,
Toxicol
Lett, Dec;82‑83:255‑61; & Cell Mol
Neurobiol
1994
Dec;14(6):675‑87; & Rossi AD, et al, Modifications of Ca2+ signaling by
inorganic mercury in PC12 cells. FASEB J 1993, 7:1507-14.
(342) Stejskal VDM,
Danersund
A,
Lindvall
A,
Hudecek
R,
Nordman
V,
Yaqob
A et al. Metal-
specific memory lymphocytes: biomarkers of sensitivity in
man. Neuroendocrinology Letters, 1999; 20: 289-98.
(365) C. Schulte-
Uebbing
, “
Umweltbedingte
Frauenkranheiten
”,
Sonntag-Verlag, Stuttgart, 1996; &
Umweltmedizin
in der
Frauenheilkunde
,
Arztezeitschr
.
Naturheilkunde
, 35(2):9-17.
(367)(a) Gerhard I, “Amalgam from
gynacological
view”, Der
Frauenarzt
, 1995,36(6): 627-28; & (b)“
Schdstoffe
und
Fertillitatsstorungen
”,
Schwermetalle
und
Mineralstoffe
,
Geburtshilfe
Frauenheikd
,
1992, 52(7):383-396; & (c) Gerhard I, “Reproductive risks of heavy metals
and pesticides in women”, in: Reproductive Toxicology,
M.Richardson
(ed.),
VCH
Weinhelm
, 1993, 167-83; & (d)
“Infertility with women by environmental illnesses, JD. Kruse-
Jarres
(
Ed.),
1993, 51-68. Gerhard I,
(369) Mercury and nickel allergy: risk
factors in fatigue and autoimmunity. Neuroendocrinology Letters 1999;
20:221-228
Sterzl
I,
Prochazkova
J, Stejskal VDM et
al,;
& The beneficial
effect of amalgam replacement on health in patients with
autoimmunity. Neuro Endocrinol Lett. 2004 Jun;25(3):211-
Prochazkova
J,
Sterzl
I,
Kucerova
H,
Bartova
J, Stejskal VD; 8.
www.melisa.org
& Effects of HgCl2 on the expression of
autoimmune responses and disease in diabetes‑prone (DP) BB
rats. Autoimmunity 1997;26(3):173‑87.
Kosuda
LL,
Greiner DL,
Bigazzi
PE.
(372) Atchison WD. Effects of
neurotoxicants on synaptic transmission.
Neurotoxicol
Teratol
1998,
10(5):393- 416; &
Sidransky
H, Verney E, Influence of lead acetate and
selected metal salts on tryptophan binding
to rat hepatic nuclei.
Toxicol
Pathol
1999, 27(4):441-7;
& Shukla GS, Chandra
SV,
Effect
of interaction of Mn2+withZn2+, Hg2+, and Cd2+ on some neurochemicals
in rats.
Toxicol
Lett 1982, 10(2-3):163-
8;
&Brouwer M et al,
Functional changes induced by heavy metal ions. Biochemistry, 1982,
21(20): 2529-38.
(374)
Benkelfat
C et al, Mood
lowering effect of tryptophan depletion. Arch Gen Psychiatry, 1994,
51(9): 687- 97; &
Young SN et al, Tryptophan depletion causes a rapid lowering of mood in normal
males. Psychopharmacology, 1985, 87(2):173-77; &
Smith KA et al, Relapse of depression after depletion of tryptophan,
Lancet 1997, 349(9056):915-19; & Delgado PL et al, Serotonin function,
depletion of plasma
tryptophan, and
the mechanism of antidepressant action. Arch Gen
Psychiatry 1990, 47(5):411-18.
(381)
Demitrack
MA, Dale
JK. Evidence for impaired activation of the
hypothalamic-pituitary-adrenal axis
in patients with chronic fatigue
syndrome. J Clin Endocrinol
Metabol
1991;
73:1224-1234; & Turnbull
AV,
Rivier
C. Regulation of the HPA axis by
cytokines. Brain
Behav
Immun
1995; 20:253-75; & Ng TB, Liu WK. In Vitro Cell
Dev Biol 1990 Jan;26(1):24‑8. Toxic effect of heavy metals on cells
isolated from the rat adrenal and testis.
(386) Great Smokies Diagnostic Lab, research web pages (by
condition)
http://www.gsdl.com;
&
Doctors Data Lab , http://www.doctorsdata.com ,
inquiries @doctors data.com, www.doctorsdata.com, &
MetaMetrix
Lab, www.metametrix.com; &(d)
Biospectron
Lab, LMI, Lennart
Månsson
International
AB, lmi.analyslab@swipnet.se http://home.swipnet.se/misac/research11.html#biospectrons
& (e)
Great Plains Laboratory www.greatplainslaboratory.com/test19.html
(395) Baranski B.
Environmental Health Perspectives 1993; 101(suppl 2): 85-90;
& (b)Baranski B. Effect of mercury on the sexual
cycle and prenatal and postnatal development of progeny. Med
Pr
1981; 32(4): 271-6; &(c) Hooper A, Mercury
poisoning in Dentistry, Wisconsin Medical J, Aug 1980, vol 79; & (d)
Shapiro IM,
Cornblath
DR, Sumner
AJ. Neurophysiological and neuropsychological function in
mercury-exposed dentists. The Lancet 1982;
1:1147-1150; &(e)
Uzzell
BP and
Oler
J. Chronic low-level
mercury exposure
and neuropsychological functioning. J of Clin
and
Exper
Neuropsych
1986;
8:581-93; & (f) Epidemiological case definitions of peripheral
neuropathy, Ger. F,
Letz
R. Neurotoxicology. 2000 Oct;21(5):761-8. & (g) Residual
neurologic deficits 30 years after occupational exposure to elemental mercury,
Letz
R, Ger F, et al, Neurotoxicology. 2000
Aug;21(4):459-
74 ;
& (h) Chronic
inorganic mercury induced peripheral neuropathy, Chu CC, Wu TL, et
al, Acta Neurol Scand. 1998 Dec;98(6):461-5
(405) Stejskal
J, Stejskal V. The role of metals in autoimmune diseases and the link
to
neuroendocrinology
Neuroendocrinology
Letters,
20:345‑358, 1999. www.melisa.org/knowledge/education14.html
(409) Bernard S,
Enayati
A, Redwood L, Roger H,
Binstock
T. Autism: a novel form of mercury poisoning. Med
Hypotheses 2001 Apr;56(4):462-71.
http://www.autism.com/ari/mercurylong.html :
& Yazbak
FE(MD,FAAP) Autism 99 : A National Emergency,
www.garynull.com/documents/autism_99.htm
& Amy
Holmes, MD, Autism Treatment
Clinic, Baton Rouge,
La,
http://www.healing-arts.org/children/holmes.htm#wethink
(412) (a) Moreno-
Fuenmayor
H,
Borjas
L, Arrieta A,
Valera
V,
Plasma excitatory amino
acids in
autism. Invest Clin
1996,37(2):113-
28;&
Carlsson ML. Is infantile
autsim
a
hypoglutamatergic
disorer
? J Neural
Transm
1998,
105(4-5): 525-35. & (b)Rolf LH,
Haarman
FY,
Grotemeyer
KH,
Kehrer
H. Serotonin and
amino acid content in platelets of autistic
children. Acta
Psychiatr
Scand
1993, 87(5): 312-
6; &
(c)
Naruse
H, Hayashi
T,
Takesada
M, Yamazaki K. Metabolic changes in aromatic amino acids and
monoamines in infantile autism and
a new related
treatment, No
To
Hattatsu
, 1989, 21(2):181-9;
(413)
Autism-Mercury@egroups.com,
web group of
parents with autistic kids and autism doctors and
researchers;
www.myflcv.com/autismc.html
& Autism,
PDD, and
Immune Reactive
Conditions; the mercury connection, www.flcv.com/kidshg.html
& Edelson SB, Cantor DS. Autism:
xenobiotic influences.
Toxicol
Ind Health
1998; 14(4): 553-
63; www.edelsoncenter.com/Autism/autism.htm
&
Liska
, DJ. The
detoxification enzyme
systems. Altern
Med Rev 1998. 3(3):187-98.
(
416)(
a)
Plaitakis
A,
Constantakakis
E. Altered metabolism of excitatory amino acids, N-acetyl-aspartate
and – acetyl-aspartyl-glutamate in
amyotrophic lateral sclerosis. Brain Res Bull 1993;30(3-4):381-
6 &
(b)Rothstein JD, Martin LJ,
Kuncl
RW. Decreased glutamate transport by the
brain and spinal cord in ALS. New Engl J Med 1992, 326: 1464-
8:&
(c) Leigh
Pn
. Pathologic
mechanisms in ALS and other motor neuron diseases. In:
Calne DB(Ed.), Neurodegenerative Diseases, WB
Saunder
Co., 1997, p473-88;
&
P
.Froissard
et al,
Universite
de
Caen, “Role of glutathione metabolism in the glutamate-induced programmed cell
death of neuronal cells”
Eur
J
Pharmacol
,
1997, 236(1): 93-99; & (d) Kim P, Choi BH. “Selective inhibition of
glutamate uptake by mercury in cultured mouse astrocytes”, Yonsei Med J 1995;
36(3): 299-305; & Brookes N. In vitro evidence for the role of
glutatmate
in the CNS toxicity of
mercury. Toxicology 1992,
76(3):245-56; & Albrecht J,
Matyja
E. Glutamate: a potential mediator of inorganic mercury
toxicity.
Metab
Brain Dis 1996;
11:175-84; &(e) Tirosh O, Sen CK, Roy S, Packer L. Cellular
and mitochondrial changes in glutamate-induced HT4 neuronal cell
death Neuroscience. 2000;97(3):531-
41;
(423)
T.Barber
, “Inorganic mercury
intoxification
similar to ALS”, J of
Occup
Med, 1978, 20:667-9; & Brown IA. Chronic
mercurialism
-a cause of the clinical syndrome of
ALS. Arch Neurol Psychiatry 1954, 72:674
- 9
;
& Schwarz S,
Husstedt
I. ALS after accidental injection of mercury. J Neurol
Neurosurg
Psychiatry 1996, 60:698;
&
Felmus
MT, Patten
BM,
Swanke
L; Antecedent
events
in amyotrophic lateral
sclerosis Neurology
1976 Feb;26(2):167‑72; & Patten BM, Mallette LE. Motor neuron
disease: retrospective study of
associated abnormalities
. Dis
Nerv
Syst 1976 Jun;37(6):318‑21; &
Kantarjian
A, "A syndrome clinically resembling
amyotrophic lateral sclerosis following chronic
mercurialism
", Neurology 11:639‑644 (1961)
(424) Munch G;
Gerlach M; Sian J; Wong A;
Riederer
P. Advanced glycation end products in
neurodegeneration: more than early
markers of
oxidative
stress? Ann Neurol 1998 Sep;44(3 Suppl 1
):S
85‑8.
(432) Sutton KG,
McRory
JE, Guthrie H,
Snutch
TP. P/Q-type calcium channels mediate the
activity-dependent
feedback of
syntaxin-1A. Nature 1999, 401(6755):800-
4;
(440) Kidd
RF. Results of dental amalgam removal and mercury
detoxification. Altern
Ther
Health Med
2000 Jul;6(4):49‑55; &
Gary Null, www.garynull.com/Documents/Dental/Amalgam/Amalgam6.htm
(441)(a)National
Academy of Sciences, National Research Council, Committee on Developmental
Toxicology,
Scientific Frontiers in Developmental Toxicology and Risk
Assessment,
June 1, 2000, 313 pages; & Evaluating Chemical and
Other Agent Exposures for Reproductive and Developmental Toxicity Subcommittee
on Reproductive and Developmental Toxicity, Committee on Toxicology, Board
on Environmental Studies and Toxicology, National Research Council, National
Academy Press, 262 pages, 6 x 9, 2001; &(b) National Environmental Trust
(NET), Physicians for Social Responsibility and the Learning Disabilities
Association of America, "Polluting Our Future: Chemical Pollution in the
U.S. that Affects Child Development and Learning" Sept
2000; www.safekidsinfo.org
(442)
Olanow
CW,
Arendash
GW. Metals and free radicals in neurodegeneration. Curr
Opin
Neurol 1994, 7(6):548-58; &
Kasarskis
EJ(MD),
Metallothionein in ALS Motor
Neurons(
IRB
#91-22026),
FEDRIP DATABASE,
National Technical Information Service(NTIS), ID: FEDRIP/1999/07802766.
(443) Troy CM,
Shelanski
ML. Down-regulation of
copper/zinc superoxide
dismustase
causes apoptotic
death in PC12 neuronal cells. Proc. National
Acad
Sci, USA, 1994, 91(14):6384-7; & Rothstein JD,
Dristol
LA,
Hosier B, Brown
RH,
Kunci
RW. Chronic inhibition of
superoxide
dismustase
produces apoptotic
death of spinal
neurons. Proc Nat
Acad
Sci, USA,
1994, 91(10):4155-9.
(444) (a) Beal MF. Coenzyme Q10
administration and its potential for treatment of neurodegenerative
diseases.
Biofactors
1999, 9(2-4):262-
6;
&
DiMauro S, Moses LG; CoQ10 Use Leads To Dramatic Improvements In
Patients With Muscular Disorder, Neurology, April 2001;&
C.Schultz
et al, CoQ10 slows progression of Parkinson’s
Disease; Archives of Neurology, October 15, 2002 & Matthews
RT, Yang L, Browne S,
Baik
M, Beal
MF. Coenzyme Q10 administration increases brain mitochondrial
concentrations and exerts neuroprotective effects. Proc Natl
Acad
Sci U S A 1998 Jul 21;95(15):8892-7; & Schulz JB,
Matthews RT, Henshaw DR, Beal MF. Neuroprotective strategies
for treatment of lesions produced by mitochondrial toxins: implications for
neurodegenerative diseases. Neuroscience 1996 Apr;71(4):1043-8;
&
Idebenone
-
Monograph. A potent antioxidant and stimulator of nerve growth
factor. Altern Med Rev 2001 Feb;6(1):83-
86;
&
(b)Nagano S, Ogawa Y,
Yanaghara
T, Sakoda
S. Benefit of a combined treatment with
trientine
and ascorbate in
familial amyotrophic
lateral sclerosis model mice.
Neurosci
Lett 1999, 265(3):159-
62;
&
(c) C. Gooch et al, Eleanor
& Lou
Gehrig MDA/ALS Center
at Columbia-Presbyterian Medical Center in New
York; ALS Newsletter Vol. 6, No.
3 June 2001; & (d) Kidd PM., Neurodegeneration from mitochondrial
insufficiency: nutrients, stem cells, growth factors, and prospects for brain
rebuilding using integrative management. Altern Med Rev. 2005
Dec;10(4):268-293.
(449) Schaumburg H,
Spencer P: Toxic Neuropathies. Neurology 29:431, 1979;
& Levine
SP;
Cavender GD;
Langolf
GD;
Albers JW. Elemental mercury exposure:
peripheral neurotoxicity. Br J Ind Med
1982 May;39(2):136‑9
(451)
Miszta
H;
Dabrowski
Z. Effect of mercury and combined effect of mercury on the activity
of
acetylcholinesterase of
rat lymphocytes during in vitro incubation. Folia
Haematol
Int Mag
Klin
Morphol
Blutforsch
1989;116(1):151‑5;
& Bear
, David;
Rosenbaum, Jerrold; Norman, Robert. Aggression in cat
and
human precipitated
by
a cholinesterase inhibitor. The journal Psychosomatics,
July 1986
, vol. 27, #7,
pgs. 535‑536;
& Devinsky
, Orrin;
Kernan
,
Jennifer: Bear, David. Aggressive Behavior Following
Exposure to Cholinesterase
Inhibitors. Journal of Neuropsychiatry, vol. 4, #
2,
Spring 1992,
pgs. 189‑199.
(453) Blumer W,
"Mercury toxicity and dental amalgam fillings", Journal of
Advancement in Medicine, v.11, n.3, Fall 1998, p.219
(457) International
Labor Organization, Mental health in
the workplace in Finland, Germany, United
Kingdom and United States. Oct
2000, www.ilo.org/public/english/bureau/inf/pr/2000/37.htm
(462) Mercury induces
cell cytotoxicity and oxidative stress and increases beta‑amyloid secretion and
tau phosphorylation in SHSY5Y neuroblastoma cells. J
Neurochem
2000 Jan;74(1):231‑6,
Olivieri
G;
Brack
C; Muller‑
Spahn
F;
et
al,;
& (b) Formation of hydrogen peroxide and
hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism
of cell death in Alzheimer's disease and Parkinson's disease. Free
Radic
Biol Med. 2002 Jun 1;32(11):1076-83,
Tabner
BJ, Turnbull S, El-
Agnaf
OM,
Allsop
D. ;
&(c) Ho PI, Collins SC, et al; Homocysteine potentiates
beta-amyloid neurotoxicity: role of oxidative stress. J
Neurochem
. 2001 Jul;78(2):249-53.
(464) Walsh,
WJ, Health Research Institute, Autism and Metal
Metabolism, www.hriptc.org/autism.htm
, Oct
20, 2000; & Walsh WJ, Pfeiffer Treatment
Center, Metal‑Metabolism and Human Functioning, 2000,;
http://www.hriptc.org/metal_metabolism.html
&
© HRI
-Pfeiffer Center Autism Study; paper
presented to Dan Conference, Jan 2001;
(465) Walsh WJ,
Health Research Institute, Biochemical Treatment of Mental Illness and Behavior
Disorders,
Minnesota Brain Bio
Assoc, Nov 17, 1997; http://www.hriptc.org/Minnesota.htm;
& William J. Walsh, Laura B.
Glab
, and Mary
L.
Haakenson
;
Pfieffer
Treatment Center, Biochemical Therapy and Behavior Outcomes;
2000, http://www.hriptc.org/btbres.htm
(
469)BrainRecovery.com
,
the book, by David Perlmutter
MD; Perlmutter Health Center, Naples, Florida,
http://www.perlhealth.com/about.htm;
&(b) M.M. van
Benschoten
, ““Acupoint Energetics
of Mercury Toxicity and Amalgam Removal with Case Studies,”” American Journal
of Acupuncture, Vol. 22, No. 3, 1994, pp. 251-262;
& M.M.
Van
Benschoten
and Associates, Reseda,
Calif. Clinic; http://www.mmvbs.com/
http://www.fda.gov/ohrms/dockets/dailys/01/Jan01/011201/emc000010.txt
(470) Dr. Garth
Nicholson, Institute for Molecular Medicine, Huntington
Beach, Calif.
,
www.immed.org
& Michael Guthrie,
R.Ph
. ImmuneSupport.com 07‑18‑2001 Mycoplasmas
– The Missing Link in Fatiguing Illnesses, ,
www.immunesupport.com/library/showarticle.cfm?ID=3066; & New
Treatments for Chronic Infections Found in Fibromyalgia Syndrome,
Chronic Fatigue Syndrome, Rheumatoid Arthritis, and Gulf War
Illnesses, www.immed.org/reports/autoimmune_illness/rep1.html ;
& Prof. Garth L. Nicolson, Chronic Fatigue Syndrome,
Fibromyalgia Syndrome and Other Fatigue
Conditions, www.immed.org/illness/fatigue_illness_research.html; & Dr.
G. Nicholson, Institute for Molecular Medicine, New Treatments
for Chronic Infections Found in Fibromyalgia Syndrome, Chronic
Fatigue Syndrome, Rheumatoid Arthritis, Multiple Sclerosis,
Amyotrophic Lateral Sclerosis, and Gulf War
Illnesses, www.immed.org/reports/autoimmune_illness/rep1.html
& (b)
Immunosciences
Lab,
www.immuno‑sci‑lab.com/index2.html
(475)
As thimerosal was removed
from childhood vaccines, the number of neurodevelopmental disorders decreased
in the US
. June 2006,
& (b
Exposure
to mercury from thimerosal-containing vaccines was associated with an increased
risk of neurodevelopmental problems in infants from 1992-199
)
7.
Apr
2005; &(c)
Rates of autism, speech disorders, mental retardation,
infantile spasms, and thinking abnormalities were higher in children exposed to
higher thimerosal levels
(476) Dr
Thomas
Verstraeten
, US
Centres
for
Disease Control and Prevention, Summary Results: Vaccine
Safety Datalink
Project ‑ a database of 400,000 children , May 2000; & Geier
M.R., Geier DA;
Timerosal
in Childhood Vaccines,
Neurodevelopmental Disorders, and Heart Disease in the U.S. ; J of Amer
Physicians and Surgeons, Vol 8(1), Spring 2003
(477) Lars
Landner
and Lennart
Lindestrom
. Swedish
Environmental Research
Group(
MFG),
Copper
in society
and the Environment
,
2nd revised edition. 1999.
(480)
Salzer
HM, Relative hypoglycemia as a cause of
neuropsychiatric illness, J National Med Assoc, 1996,
58(1): 12-17; &
Heninger
GR et al, Depressive symptoms, glucose tolerance,
and insulin tolerance, J Nervous and Mental Dis, 1975; 161(6):421-32; &
Winokur
A et al, Insulin resistance in patients with major
depression,
Am
J Psychiatry, 1988, 145(3): 325-30.
(481)
Virkkunen
M,
Huttunen
MO; Evidence for abnormal glucose
tolerance among violent
offenders,
Neuropsychiobilogy
, 1982, 8:30-40; &(b) Markku I,
Virkkunen
L; Aggression, suicidality, and serotonin,
J Clinical
Psy
1992, 53(10): 46-51; & (c) Assessment of
chronic neuropsychological effects of
mercury
vapour
poisoning in chloral-alkali plant workers.
Bosn
J Basic Med Sci. 2002 Dec;2(1-2):29-34.
Pranjic
N,
Sinanovic
O, et al.
(482
)
Linnoila
M
et al, Low serotonin metabolite differentiates impulsive from
nonimpulsive
violent behavior,
Life Sciences, 1983, 33(26): 2609-2614; & Lopez-
Ibor
JJ , Serotonin and psychiatric disorders,
Int
Clinical
Psychopharm
, 1992, 7(2): 5-11.
(483) Thomas DE et
al, Tryptophan and nutritional status in patients with senile dementia,
Psychological Med
1986,
16:297-305;
&
Yaryura
-Tobias JA et al, Changes in serum
tryptophan and glucose in psychotics and neurotics, Nutrition, No.4557, p1132;
Carney MWP, Brit Med J, 1967, 4:512-516.
(485) Dr. Hulda
Clark,
The Cure for all Diseases
, New Century Press,2000,
www.drclark.net (amalgam replacement and treatment for parasites/
bacteria)(
U.S. CDC confirms parasites common in those with
chronic immune conditions)
& U.S. Center for Disease
Control,
Parasites(
widespread exposures),
www.dpd.cdc.gov/dpdx/HTML/Para_Health.htm
;
www.cdc.gov/ncidod/diseases/list_parasites.htm
http://www.cdc.gov/ncidod/dpd/parasites/ascaris/prevention.htm
www.cdc.gov/healthypets/browse_by_diseases.htm
;
www.cdc.gov/ncidod/diseases/index.htm
(486) Dr. Hulda
Clark, The Cure for All Cancers, 1998, www.drclark.net; &
Gerson Clinics, www.gerson.org.
& Charlotte Du
Bois and John
Lubecki
,
The End of Cancer
,
Nelson’s Books, 2003; & The Cancer
Homepage
www.curezone.com/diseases/cancer/cancer_dental_risk.asp
& Dr. Hulda
Clark, The Cure of HIV/AIDS, New Century Press, 1993.
(487) Haut
MW; Morrow LA; Pool D; Callahan TS; Haut JS; Franzen
MD. Neurobehavioral effects of
acute exposure to inorganic mercury
vapor. Appl
Neuropsychol
1999;6(4):193‑200.
(490) Rojas
M, Olivet
C .
Occupational exposure and
health effects of metallic mercury among dentists and dental assistants: a
preliminary study. Valencia, Venezuela; Acta
Cient
Venez
2000;51(1):32‑8;
&
Nadorfy
‑Lopez
E, Bello B. Skeletal muscle abnormalities associated with
occupational exposure
to mercury
vapors.
Histol
Histopathol
2000
Jul;15(3):673‑82.
(495) Kang JH,
Eum
WS. Enhanced oxidative damage by the
familial amyotrophic lateral sclerosis‑associated
Cu,Zn
‑superoxide
dismustase
mutants.
Biochem
Biophys
Acta 2000 Dec 15;1524(2‑3):162‑70; & (b) JH,
Eum
WS. Enhanced oxidative damage by the familial amyotrophic lateral
sclerosis‑ associated
Cu,Zn
‑superoxide
dismustase
mutants.
Biochem
Biophys
Acta 2000 Dec 15; 1524(2‑3): 162‑70; &
© Liu H, Zhu H, Eggers DK,
Nersissian
AM, Faull KF, Goto JJ, Ai J, Sanders‑Loehr
J,
Gralla
EB, Valentine JS.
Copper(
2+) binding to the surface residue cysteine 111 of
His46Arg human copper‑zinc superoxide
dismustase
,
a familial amyotrophic lateral sclerosis
mutant. Biochemistry 2000 Jul 18;39(28):8125‑32; &(d) Wong PC,
Gitlin JD; et
al, Copper
chaperone for
superoxide
dismustase
is essential to
activate mammalian Cu/Zn superoxide
dismustase
. Proc
Natl
Acad
Sci U S A 2000 Mar 14;97(6):2886‑91; &
(e)
Kruman
II, Pedersen WA, Springer JE,
Mattson MP. ALS‑linked Cu/Zn‑SOD mutation increases
vulnerability of
motor neurons
to
excitotoxicity by a mechanism involving increased oxidative stress and
perturbed calcium homeostasis. Exp Neurol 1999 Nov;160(1):28‑39
(496) Doble
A. The role of excitotoxicity in neurodegenerative disease:
implications for therapy.
Pharmacol
Ther
1999 Mar;81(3):163‑221;
&
Urushitani
M,
Shimohama
S. N‑methyl‑D‑aspartate
receptor‑mediated mitochondrial
Ca(
2+) overload
in acute excitotoxic motor neuron death: a mechanism distinct from
chronic neurotoxicity after Ca(2+) influx. J
Neurosci
Res 2001 Mar 1;63(5):377‑87;
& Cookson MR, Shaw PJ. Oxidative stress
and motor neurons disease. Brain
Pathol
1999 Jan;9(1):165‑86
(497) Torres‑Aleman
I, Barrios V,
Berciano
J. The peripheral
insulin‑like growth factor system in
amyotrophic lateral
sclerosis and in multiple sclerosis. Neurology 1998 Mar;50(3):772‑
6 ;
& Dall R,
Sonksen
PH et
al; The effect of four weeks of supraphysiological growth
hormone administration on the insulin‑like growth factor axis
in women and men. GH‑2000 Study Group. J Clin
Endocrinol
Metab
2000 Nov;85(11):4193‑200; & Pons
S, Torres-Aleman I. Insulin-like growth factor-I stimulates dephosphorylation
of
ikappa
B through the serine phosphatase
calcineurin. J Biol Chem 2000 Dec 8;275(49):38620-
5;
(498) Lai EC,
Rudnicki
SA. Effect of recombinant human insulin‑like growth factor‑I
on progression
of ALS. A placebo‑controlled
study. Neurology 1997 Dec;49(6):1621‑30; & Yuen EC, Mobley
WC. Therapeutic applications of neurotrophic factors in disorders
of motor
neurons and peripheral
nerves. Mol Med Today 1995 Sep;1(6):278‑86; & Dore S,
Kar S,
Quirion
R. Rediscovering an old friend,
IGF‑I: potential use in the treatment of neurodegenerative
diseases. Trends
Neurosci
1997
Aug;20(8):326‑31;
&
Couratier
P, Vallat JM. Therapeutic
effects of neurotrophic factors in
ALS; Rev
Neurol
(Paris). 2000 Dec;156(12):1075‑7. French
(502)
Toxic
Neuropathy,
Jonathan
S
Rutchik
,
MD, MPH,
http://emedicine.medscape.com/article/1175276-overview
(521)
Guermonprez
L,
Ducrocq
C,
Gaudry-Talarmain
YM. Inhibition of acetylcholine
synthesis and tyrosine nitration induced by
peroxynitrite
are differentially prevented by antioxidants. Mol
Pharmacol
2001 Oct;60(4):838-46; & Mahboob
M, Shireen KF, Atkinson A, Khan AT. Lipid peroxidation and
antioxidant enzyme activity in different organs of mice exposed to low level of
mercury. J Environ Sci Health B. 2001 Sep;36(5):687-97.
(522)
Nutrition Supplements Found Effective for Metal Disorders, Dr. Julia
Rucklidge
, University
of Canterbury,
Journal of Attention Disorders
, January
2010 (
EMPowerPlus
,
TrueHope
)
(523) CBS Television
Network,” 60 Minutes”, television program narrated by Morley
Safer, December 12, 1990
www.vimy‑dentistry.com/tttoc.htm#_Toc499123411
(
524)(
a)
Urushitani
M,
Shimohama
S. The role of nitric oxide in amyotrophic lateral sclerosis.
Amyotroph
Lateral
Scler
Other Motor Neuron
Disord
2001 Jun;2(2):71-81;
&(b)
Torreilles
F, Salman-
Tabcheh
S, Guerin M,
Torreilles
J. Neurodegenerative
disorders: the role of
peroxynitrite.Brain
Res Brain Res Rev 1999 Aug;30(2):153-63; & (c)Aoyama K, Matsubara K,
Kobayashi S. Nitration of manganese superoxide
dismutase in cerebrospinal fluids is a
marker for
peroxynitrite
-mediated oxidative stress in
neurodegenerative diseases. Ann Neurol 2000
Apr;47(4):524-7; &(d)
Guermonprez
L,
Ducrocq
C,
Gaudry-Talarmain
YM. Inhibition of acetylcholine synthesis and tyrosine nitration
induced by
peroxynitrite
are differentially
prevented by antioxidants. Mol
Pharmacol
2001 Oct;60(4):838-46
(525) Cheshire,
William P., Jr. The shocking tooth about trigeminal neuralgia. New
England Journal of Medicine, Vol. 342, June 29, 2000, p. 2003,
& Bergman
M,
Ginstrup
O, Nilsson B. Potentials of and currents between dental metallic restorations.
Scand
J Dent Res
1982;90:404
-8;
&
Hugoson
A. Results obtained from patients
referred for the investigation of complaints related to oral galvanism.
Swed
Dent J
1986;10:15
-28;(b)
& Muller AW, Van Loon LA, Davidson CL. Electrical
potentials of restorations in subjects without oral complaints. J Oral
Rehabil
1990;17:419
-24; &
(c)
Raue
H., "Resistance to therapy; Think of
tooth fillings", Medical Practice, vol. 32, n.72, p.2303- 2309, 6 Sept
1980(over 1000 cases) &(d) Johann Lechner, "Dental
Materials and Psychoneuroimmunology Conference".
Danderyd
Hospital, 14-16 August,
1998; www.melisa.org/archive/6th_melisa_study_group.html
(532) El-
essawy
Dental Clinic
www.el-essawy.com (
large
number of cases-most chronic conditions improve after amalgam
replacement) www.wholisticresearch.com/info/artshow.php3?artid=7
(534)
Pneuropsychological
disorders after occupational exposure
to mercury vapors, Rev Neurol 2000 Oct 16-31;31(8):712-6 Tirado V, Garcia
MA, Franco
A.,;
& Chronic
neurobehavioural
effects of mercury poisoning on a group of chemical workers.
Brain
Inj
2000 Sep;14(9):797-814 Powell
TJ.
(535) K. Sullivan,
Evidence Implicating Amalgam in Alzheimer’s Disease,
www.bhoffcomp.com/coping/amalgam.html
(538) C.
Malmstrom, DDS, Medical Research and Development,
http://home.swipnet.se/misac/maineng.html
& http://home.swipnet.se/misac/infpatient.html
(Over 2000
cases, about 90%
signif
. improvement)
&
Malmstrom detox high fiber
diet( http://home.swipnet.se/misac/vararticles8.html
)
& Health,
Teeth, and Mercury Toxicity, www.earthtym.net/merc‑tox.htm; & Eric
Davis Dental Center, www.ericdavisdental.com/the_program.htm
(543) U.S. Centers for Disease Control,
National Center for Health
Statistics, NHANES
III study(thousands
of people’s health monitored),
www.flcv.com/nhanes3.html
http://www.mercola.com/article/mercury/no_mercury.htm
(550)
Life Enhancement Foundation (MDs), Disease Prevention and
Treatment, Expanded Forth Edition, 2003
(551) Dr.
Harald
Hamre(
Norwegian physician treating mercury
toxicity) ,
Amalgam and Illness,
1998.
(552) Lindh U,
Hudecek
R,
Danersund
A, Eriksson
S,
Lindvall
A.
, Removal
of dental amalgam and other metal alloys supported by antioxidant therapy
alleviates symptoms and improves quality of life in patients with
amalgam-associated ill health.
Neuroendocrinol
Lett 2002 Oct-Dec;23(5-6):459-82. (750 cases)
(555) Rat brain (Na+‑K
+)ATPase
: modulation of its ouabain‑sensitive K+‑
PNPPase
activity by thimerosal. Int J
Biochem
1983;15(1):5‑7 Lewis RN; Bowler K.; Effect of thimerosal on serum binding of
thyroid hormones, Can J
Physsiol
Pharmacol,173,
51:156-159
Bellabarba
D, and Tremblay R; &
Hokkfen
B,
Kodding
R,
Hesch
RD; Regulation of thyroid hormone metabolism in rat
liver fractions,
Biochim
Biophys
Acta 1978, 539:(1): 114-24.
(556) Aspen Clinic
for Preventive and Environ-mental Medicine in Colorado
http://curezone.org/testimonials/003.htm; &
Alpine Holistic Health Clinic, Dr. Lewis Cone, Plano, Texas,
www.drlewiscone.com/toxic_metals.htm; & ICNR Case Study
#11 www.icnr.com/cs/cs_11.html
(557) Psychiatric
Disturbances and Toxic Metals, Townsend Letter for Doctor's & Patients
April 2002; &
Alternative
& Complementary Therapies (a magazine for doctors), Aug 2002.
(560) Mercury connection to autism and schizophrenia
through enzymatic blockages, B Windham (Ed
) ,
www.flcv.com/autismgc.html
(564) Metal-triggered
structural transformations, aggregation, and fibrillation of human
alpha-synuclein. A possible molecular NK between Parkinson's disease and
heavy metal exposure. J Biol Chem. 2001 Nov 23;276(47):44284-96.
Uversky
VN, Li J, Fink AL.
Epub
2001 Sep 11
(565) Quantitative
analysis of rapid pointing movements in Cree subjects exposed to mercury and in
subjects with neurological deficits. Environ Res. 1999 Jan;80(1):50-63.
Beuter
A, de Geoffroy A, Edwards R.
(566) Mercury,
dental amalgam, and hearing
loss.Cesarani
A,
Minoia
C,
Pigatto
PD,
Guzzi
G., Int J
Audiol
. 2010
Jan;49(1):69-70.
(574) Pollutants
appear to be the cause of the huge rise in degenerative neurological
conditions. Public Health, Aug 2004. Pritchard C. et al,
(577)
Joachim
Mutter et al
,
Alzheimer Disease: Mercury as pathogenetic factor and
apolipoprotein E as a
moderator,
Neuroendocrinol
Lett 2004;
25
(5):331–339;
& (b)
Mutter J,
Daschner
F, et
al, Amalgam risk assessment with coverage of references up to 2005]
,
Gesundheitswesen
. 2005 Mar;67(3):204-16.
(580) Life Extension Foundation (MDs
),
Disease
Prevention and Treatment
, Expanded 4
th
Edition, 2003
,
http://www.life-enhancement.com/
(581) Heavy Metal and Chemical
Toxicity, Dietrich
Klinghardt
, MD,
Ph.D.
www.neuraltherapy.com/chemtox.htm
; & Mercury Toxicity
and Systemic Elimination Agents, D.
Klinghardt
&
J
Mercola(
DO), J of Nutritional and Environmental
Medicine, 2001, 11:53-62; &
Amalgam Detox
,
Klinghardt
Academy of Neurobiology, 2008
(582) R.F Kidd, Results of Dental
Amalgam Removal and Mercury Detoxification using DMPS and Neural Therapy,
Alternative Therapies, July 2000, Vol 6, No 4, p49-55.
(585)
Aluminum Hydroxide: Another Poison Pediatricians Inject in
Babies; IMVA,
http://imva.info/index.php/vaccines/aluminum-hydroxide/
; & (b) “Vaccines Show Sinister Side” March
23,2006,
www.straight.com/content.cfm?id=16717
;
(c)
Blaylock, Russell. The Blaylock
Wellness Report Vol 1, Issue 1; & (d) Cave,
Stephanie,
Mitchell
, Deborah “What Your Doctor May Not Tell You About Children’s
Vaccinations”, Warner Books, 01 September, 2001; & (e) Waly, M. et al
Activation of methionine synthase by insulin-like growth factor-1 and dopamine:
a target for neurodevelopmental toxins and thimerosal. Department of
Pharmaceutical Sciences, Northeastern University. Molecular Psychiatry
(2004) 1-13; & (
f) Haley
, Boyd. Mercury
and Thimerosal Toxicity: A Factor in Autism; & (g) Dr.
Fudenberg’s
comments above were from his speech at the NVIC International Vaccine
Conference, Arlington VA September, 1997; & (h)
http://www.chinadaily.com.cn/china/2006-03/25/content_552145.htm
(598)
The Blaylock Wellness Report, Inflammatory Conditions, Vol 5, No.
3, Feb 2008, & Food Additives,
What
you
eat can kill you, Vol 4, No. 10,
http://www.blaylockreport.com/
References not found
here
www.flcv.com/amalg6.html